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 Xenopus ARVCF (xARVCF), a member of p120-catenin subfamily, binds 
cadherin cytoplasmic domains to enhance cadherin metabolic stability, or when 
dissociated, modulates Rho-family GTPases. We previously found that xARVCF 
binds directly to Xenopus KazrinA (xKazrinA), a widely expressed, conserved 
protein that bears little homology to established protein families. xKazrinA is also 
known to influence keratinocyte proliferation-differentiation and cytoskeletal activity. 
In my study, I first evaluated the expression pattern of endogenous Kazrin RNA and 
protein in Xenopus embryogenesis as well as in adult tissues. We then 
collaboratively predicted the helical structure of Kazrin’s coiled-coil domain, and I 
obtained evidence of Kazrin’s dimerization/oligomerization. In considering the 
intracellular localization of the xARVCF-catenin:xKazrin complex, I did not resolve 
xKazrinA in a larger ternary complex with cadherin, nor did I detect its co-
precipitation with core desmosomal components. Instead, screening revealed that 
xKazrinA binds spectrin. This suggested a potential means by which xKazrinA 
localizes to cell-cell junctions, and indeed, biochemical assays confirmed a ternary 
xARVCF:xKazrinA:x?2-spectrin complex. Functionally, I demonstrated that xKazrin 
stabilizes cadherins by negatively modulating the RhoA small-GTPase. I further 
 vii
revealed that xKazrinA binds to p190B RhoGAP (an inhibitor of RhoA), and 
enhances p190B’s association with xARVCF.  Supporting their functional interaction 
in vivo, Xenopus embryos depleted of xKazrin exhibited ectodermal shedding, a 
phenotype that could be rescued with exogenous xARVCF. Cell shedding appeared 
to be caused by RhoA activation, which consequently altered actin organization and 
cadherin function. Indeed, I was capable of rescuing Kazrin depletion with ectopic 
expression of p190B RhoGAP. In addition, I obtained evidence that xARVCF and 
xKazrin participate in craniofacial development, with effects observed upon the 
neural crest. Finally, I found that xKazrinA associates further with delta-catenin and 
p0071-catenin, but not with p120-catenin, suggesting that Kazrin interacts 
selectively with additional members of the p120-catenin sub-family. Taken together, 
my study supports Kazrin’s essential role in development, and reveals KazrinA’s 
biochemical and functional association with ARVCF-catenin, spectrin and p190B 
RhoGAP.  
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CHAPTER I 
 
INTRODUCTION 
      
 2 
p120-catenin family 
 
Catenins were initially defined as binding cadherins (1), and with the 
exception of alpha-catenin, as possessing a central Armadillo domain mediating 
cadherin and other protein:protein interactions (2-4). Catenins consist of three sub-
families: the beta-catenin subfamily, the p120-catenin subfamily and the plakophilin 
subfamily (5). In vertebrates, the beta-catenin subfamily includes beta-catenin itself 
(homologous to Drosophila Armadillo), and plakoglobin. The p120-catenin sub-
family includes p120 itself, ARVCF (Armadillo Repeated gene in Velo-Cardio Facial 
syndrome), delta-catenin and p0071 (Fig. 1). The plakophilin-catenin subfamily 
includes the plakophilins 1 to 3. These catenins were first found to localize to the 
plasma membrane as components of adherens junctions and desmosomes (1, 6-
11). Cytoplasmic tails of classical cadherins bind to p120 subfamily proteins within 
the juxtamembrane region, and to beta-catenin subfamily proteins in the distal 
region (12-15). The cytoplasmic tails of desmosomal cadherins, desmoglein and 
desmocolin, interact with the plakophilin subfamily proteins, with p0071 (p120 
subfamily), and with plakoglobin (beta-catenin subfamily) (7, 10, 11, 16, 17). Thus, 
p0071 and plakoglobin are generally considered to be localized both at 
desmosomes and at adherens junctions (16-19), although there is still some 
controversy about the localization of p0071 (20). 
Catenins have numerous roles in varied cellular compartments (Fig. 2). 
Members of the p120-catenin subfamily, such as p120-, ARVCF- and delta-catenin, 
modulate classical cadherin stability at cell:cell junctions (21-25). p120 subfamily  
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Figure 1. Schematic diagram of p120-catenin subfamily proteins 
 
Armadillo repeats and PDZ binding motifs are depicted as shaded boxes and dark boxes, 
respectively. 
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Figure 2. The roles of p120-catenin sub-family proteins (p120-catenin is depicted).  
 
At cell-cell contacts, cadherins are stabilized upon their association with p120-catenin sub-
family members (p120-, ARVCF-, delta- and p0071-catenins). p120 sub-family members 
also modulate Rho GTPase in the vicinity of cadherin mediated cell-cell contacts. Cytosolic 
(cadherin-free) p120 sub-family members modulate Rho GTPases. p120-catenin binds to 
the Kaiso transcriptional repressor, and de-represses transcription of Kaiso target genes. 
Other p120 sub-family members are expected to have distinct nuclear functions.
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members further directly or indirectly associate with and regulate small GTPases, 
enabling intracellular signaling and cytoskeletal control (26). Further, most and 
perhaps all catenins enter the nucleus (27). Beta-catenin, for example, is well 
known to relieve TCF/LEF-mediated transcriptional repression in response to 
canonical Wnt-pathway stimulation, thereby activating target genes important in 
development or pathology/cancer (28). In the nucleus, p120-catenin binds the 
transcriptional repressor Kaiso (29-31). While further study is required to address 
unresolved issues (32, 33), we and others find that p120 likewise contributes to Wnt 
signaling through its binding and displacement of Kaiso from target gene promoters, 
and thereby the de-repression of Kaiso gene targets, some being shared targets of 
beta-catenin/ TCF (34-39). In comparison to beta- and p120-catenins, less is known 
concerning ARVCF and other catenin’s interactions and functional roles.  
 
ARVCF-catenin 
  
 ARVCF was cloned as one of the gene products deleted in Velo-Cardio 
Facial syndrome (40). In mammals, ARVCF mRNA is expressed ubiquitously 
across tissues (40). However, the protein levels of ARVCF are at least 10 fold less 
than that of p120-catenin (41). Thus, it is believed that p120 is the major p120 
subfamily protein binding to the juxtamembrane region (JMR) of classical cadherin 
proteins. Of note, ARVCF can bind to the JMR and compete with p120 for binding to 
the cadherin tail (41). This is supported by the lack of developmental defects in 
ARVCF knock-out (KO) mice (Raju Kucherlapati, Brigham and Women’s Hospital, 
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unpublished data) (see below for differences in Xenopus), whereas p120 KO mice 
are embryonic lethal (Albert B. Reynolds, Vanderbilt Univ., unpublished data). In 
contrast to p120-catenin, over-expression of mammalian ARVCF did not initially 
induce a dendritic phenotype in the NIH3T3 mouse fibroblast cell line, suggesting 
that ARVCF may be deficient in Rho modulation (41). However, our group’s 
research then indicated this to be incorrect. We found that Xenopus ARVCF 
depletion could induce gastrulation defects similar to that seen upon p120-catenin 
depletion, (and resulted in lowered cadherin protein levels), while over-expression 
of ARVCF in NIH3T3 cell induced dendritic phenotypes, each suggesting that 
ARVCF functionally interacts with Rho GTPases (22). In contrast to mice, our 
results in Xenopus indicated that ARVCF-catenin may be as central as p120 in 
amphibian development. Furthermore, the fact that ARVCF but not p120 interacts 
with protein partners such as the ERBIN scaffolding protein (42), the ZO-1 and ZO-
2  tight junction proteins (43), and the less characterized FRMPD2 protein (44), 
suggests that ARVCF-catenin has additional functions not overlapping with p120-
catenin functions.  
 
Cadherins and p120 catenin 
  
 Cadherin proteins are calcium-dependent cell adhesion molecules and they 
serve as molecular linkers between neighboring cells (45). Most cadherin proteins 
are characterized by an extracellular (EC) domain, a single transmembrane domain 
and a cytoplasmic domain (46). More than a hundred cadherins have been 
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identified to date. This cadherin super-family is divided into the classical cadherin 
family, the desmosomal cadherin family, the protocadherin subfamily and additional 
EC-domain containing proteins according to the nature of their EC and cytoplasmic 
domains (47). While classical and desmosomal cadherins each have 5 EC domains, 
their cytoplasmic sequences are largely dissimilar. This suggests that different 
proteins bind to their cytoplasmic tails. Indeed, as introduced earlier, the p120-
catenin subfamily proteins associate with classical cadherins, whereas the 
plakophilin-catenin subfamily proteins associate with desmosomal cadherins. The 
relevance of p120-catenins to cadherin function was first indicated by pioneering 
work of Ireton et al (21). In this report, the authors found that SW48 human 
carcinoma cells expressed low levels of p120 and E-cadherin. Ectopic expression of 
p120 increased E-cadherin expression, implying that p120 influences cellular levels 
of E-cadherin. Two subsequent papers support this by showing that siRNA 
mediated p120-catenin depletion in various cell lines reduced classical cadherin 
levels (E-, P-, VE-, N- cadherin) (23, 24). Furthermore cadherins were found to be 
internalized and degraded upon p120-catenin depletion (23). Thus, these early 
reports uncovered p120-catenin’s essential role as a rheostat of cadherin stability. 
However, the mechanism by which p120-catenin stabilizes cadherins is not yet well 
understood.  
 Generally, cadherin levels are believed to be regulated by four different 
mechanisms. First, E-cadherin transcription is down-regulated by transcriptional 
repressors such as slug, snail and twist during epithelial-mesenchymal-transition 
(EMT)(48). Second, E-cadherin proteins can be ubiquitilated by Hakai or MDM2 E3 
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ubiquitin ligases and subsequently degraded (49, 50). Third, the gamma secretase 
complex (including presenilin-1 protein as a component), ADAM10 metalloprotease 
or caspase-3 bind to cadherins and cleave their extracellular domains (51-54). 
Fourth, cell surface cadherins are internalized by endocytosis (55-57). Internalized 
cadherins are recycled to another membrane region to form new adherens junctions 
or are lysosomally degraded (58). Thus, increased endocytosis and lysosomal 
degradation reduces cellular cadherin levels. Regarding the mechanism by which 
p120-catenin stabilizes classical cadherins, two models have been proposed. The 
first is that p120-catenin blocks the interaction of Hakai E3 ubiquitin ligase and 
presenilin-1 to the cytoplasmic tails of cadherins (49, 59). Thus, dissociation of p120 
from cadherin tails exposes the binding sites of Hakai and presenilin, and 
subsequently, cadherin proteins are degraded or cleaved. However, since a 
presenilin inhibitor could not restore decreased cadherin levels after p120-catenin 
depletion (24), and Hakai binds only to E-cadherin (49), this model is unlikely to 
explain p120’s general mechanism in cadherin stabilization. As an alternative 
model, Xiao et al. showed that the vascular endothelial/ VE-cadherin tail fused to 
interleukin-2 receptor (IL-2R) is internalized by clathrin-mediated endocytosis and 
that p120-catenin inhibits internalization of this chimeric protein (60).  This suggests 
that p120-catenin plays a role in inhibiting cadherin endocytosis. Although it is not 
presently clear how p120-catenin protects cadherins from endocytosis, one view is 
that p120 modulates cortical actin at adherens junctions via effects upon Rho 
GTPases, thereby inhibiting the endocytosis machinery. After an initial report in 
2000, subsequent studies demonstrated the modulation of Rho GTPases including 
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RhoA, Rac1 and Cdc42, and this has thereafter been considered one of p120’s 
major molecular functions (26, 61-63). The cellular roles of p120-catenin as a 
modulator of Rho GTPases has been extensively studied in cell activities including 
actin cytoskeletal rearrangement, inflammation response via the NF-kB pathway, 
dendrite formation in neurons, malignant tumor cell migration and cell proliferation 
(64-68).  There is much evidence that Rho GTPases play a role in endocytosis (69). 
For example, over-expression of active RhoA in MDCK cells increases endocytosis 
of cell surface molecules (70). Thus, it is plausible that p120-catenin stabilizes 
cadherins via modulating Rho GTPase’s activity, and thereby cortical actin (etc.), in 
the vicinity of cadherin tails (71).  
 
Kazrin 
  
 Kazrin was initially cloned as an uncharacterized gene product expressed in 
human brain (72), and subsequently was shown to be expressed ubiquitously at the 
mRNA level in other human tissues (73). The Kazrin gene is located on human 
chromosome 1p36.21, and thus far has exhibited seven alternative splice isoforms 
(A-F and K) (Fig. 3). The KazrinA isoform has an amino-terminal leucine zipper 
motif, a central coiled-coil domain and Nuclear Localization Signal (NLS) sequence 
in its carboxyl-terminus. Our previous study found that ectopically expressed 
KazrinA protein localizes to cell:cell contacts, the cytoplasm and the nucleus in 
various cell lines.  We found that mutation of the carboxyl-localized putative NLS 
sequence abolished KazrinA nuclear localization, suggesting the NLS is functionally  
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Figure 3. Schematic comparison of Xenopus and human Kazrin isoforms  
 
The coiled-coil, poly-lysine tract (NLS) and sterile a motif (SAM) are respectively depicted 
as graded grey, black or dark grey shaded areas. LZ indicates the putative leucine zipper 
region. Alternative splicing at the carboxyl-terminus of the human KazrinA isoform results in 
an additional isoform, KazrinE, with 3 SAM domains, and KazrinK, lacking the poly-lysine 
tract. KazrinF contains an additional 97 amino acids at the amino terminus of Kazrin A. 
Each protein’s total number of amino acids is indicated. Protein structure was predicted with 
ScanProsite proteomics server. 
      
 11 
active. The coiled-coil domain is likely a protein interaction domain because in 
human Kazrin it was earlier shown to bind the peripheral desmosomal proteins 
envoplakin and periplakin (73). In Xenopus, we found that this region of Kazrin 
binds ARVCF-catenin. Kazrin’s coiled-coil bears limited sequence similarity with 
known coiled-coil domains such as FERM, SMC, HOOK, Myosin tail and SbcC. The 
role of the leucine zipper motif within the coiled-coil of KazrinA is not clear at this 
point. However, it is notable that the KazrinB-D isoforms lack a leucine zipper motif. 
Thus, the study of the functional difference between KazrinA and KazrinB-D may 
uncover the role of the leucine zipper. The KazrinE isoform is similar to KazrinA but 
includes additional amino acids in the carboxyl-terminus (74). This additional 
sequence contains three Sterile Alpha Motifs (SAM) which is a well-described 
protein interaction domain. Indeed, KazrinE interacts with the leukocyte common 
antigen-related (LAR) protein tyrosine phosphatase via its three SAM domains (74). 
KazrinF was cloned from the cDNA of a human glioma cell line, U373MG (75). 
Relative to Kazrin A, it has an additional 97 amino acids at its amino-terminus, and 
it binds to the apoptotic protein ARC (Apoptosis Repressor with Caspase 
recruitment domain), and to Bax (Bcl2-associated X protein). At this point, is not 
clear if KazrinF’s additional amino acids are responsible for these interactions. It will 
be interesting to test whether other Kazrin isoforms also interact with ARC and Bax. 
During our prior study, we found that one Kazrin isoform from human brain lacks the 
NLS, that we termed KazrinK. We compared KazrinK’s intracellular localization with 
that of KazrinA in MCF7 cells. While KazrinA resided in the nuclei of multiple cells, 
human KazrinK was absent from nuclei. This pattern was likewise observed in 
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HEK293 and Xenopus A6 cells. In all cases, the existence of variable splicing, and 
localization of the protein products, is suggestive of functionally distinct roles for 
Kazrin isoforms. 
 In Xenopus, we and another lab (that of Dr. Fiona Watt, Cambridge U.) 
independently isolated the KazrinA isoform. BLAST analysis demonstrated Xenopus 
laevis Kazrin (xKazrin) is highly homologous to human and mouse KazrinA (81% 
and 80.5% amino acid identity, respectively), and with Xenopus tropicalis Kazrin 
(Xt-Kazrin; GenBank # EU404187; 92.6% identity). Interestingly, Xt-Kazrin 
contained 28 additional residues following Kazrin’s putative coiled-coil domain.  
 In concordance with the existence of diverse isoforms, various functions 
have been proposed for Kazrins. An earlier study demonstrated that Kazrin over-
expression inhibits clathrin-mediated endocytosis of transferrin receptor, suggesting 
a role for Kazrin in endocytosis (76). Research in human keratinocytes revealed 
multiple functions for Kazrin as a structural component of the cornified envelope in 
human skin, which protects the body from the outside environment; as a modulator 
of RhoA activity affecting actin cytoskeletal rearrangements; and as a regulator of 
keratinocyte differentiation (73, 77). During Xenopus tropicalis development, Kazrin 
is involved in axis formation, eye development and ectoderm integrity (78). 
Furthermore, Kazrin knock-down in U373MG cells induced caspase activation and 
increased apoptosis, implying a function for Kazrin in cell death signaling (75). 
Although surprisingly diverse cellular effects of Kazrin have been reported, the 
mechanism(s) by which Kazrin is actually connected to such cellular activities is not 
well worked out. Our previous finding that ARVCF-catenin interacts with Kazrin 
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suggests that Kazrin may cooperate with p120-catenin family proteins in p120-
mediated endocytosis, Rho GTPase modulation and cadherin stabilization. Thus, it 
is hoped that my study of the role of the ARVCF:Kazrin complex will shed light on 
our understanding of the multifunctional Kazrin protein and of catenins. 
  Resolving the cellular localization of Kazrin is also of interest to researchers. 
Cell line, mouse embryo and human tissue studies demonstrated its localization to 
cell-cell contacts as well as the cytoplasm and nucleus (73, 77, 79). KazrinA-F 
isoforms have an NLS sequence, and they each are detected in the nucleus when 
over-expressed. However, Kazrin’s nuclear function is not yet understood. In the 
cytoplasm, Nachat el al. observed KazrinE co-localizing with stable, acetylated 
microtubule structures although the role of Kazrin binding to microtubules remains 
unclear (74). At cell-cell contacts, Kazrin was reported to be localized to 
desmosomes in keratinocytes and human skin tissue by binding to plakin proteins, 
periplakin and envoplakin (73). However, we found Xenopus Kazrin directly binds to 
ARVCF-catenin, which is best known as a component of adherens junctions in 
association with cadherins. It is possible that Kazrin localizes to different junctions 
depending on the cell type. Likewise, ARVCF-catenin may localize to more than one 
junction type, or to adherens junctions by more than one means. In my studies, I will 
address the cellular localization of the ARVCF-catenin:Kazrin complex, to assist in 
broadening our knowledge of both the Kazrin and catenin proteins. 
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CHAPTER II 
 
RESULTS 
 
      
 15 
Part One : Characterization of Xenopus Kazrin 
 
Identification of a new Xenopus Kazrin isoform 
 xKazrin is highly homologous to the human and mouse KazrinA isoforms, 
having 81% and 80% amino acid identity, respectively, whereas Xenopus tropicalis 
Kazrin (Xt-Kazrin; GenBank #EU404187), is 98.8% identical at the protein level with 
Xenopus laevis Kazrin (xKazrin) (Fig. 4). It is notable that Xt-Kazrin contains 28 
additional amino acids in the middle of Kazrin’s putative coiled-coil domain. Analysis 
of the X. tropicalis genomic sequence (Ensembl ID #ENSXETG00000013469 and 
scaffold_257) revealed that Xt-Kazrin has 9 exons, with RT-PCR analysis using X. 
laevis stage 18 neurula cDNA showing that exon 6 is alternatively spliced (Fig. 5). 
DNA sequencing confirmed that the longer isoform coded for the expected 28 
additional amino acid residues in the putative distal coiled-coil region. Being similar 
in structure and length to human Kazrin isoform A, we named the short xKazrin 
isoform xKazrinA. The long isoform was named xKazrinB.  
 
Expression of Kazrin during X. laevis development 
 To assess xKazrin mRNA expression during X. laevis development, I 
conducted RT-PCR using primers designed to detect the two xKazrin splice 
isoforms. While xKazrinB transcripts were detected from the one-cell embryo 
through tadpole stages, xKazrinA transcripts were only found during or after 
gastrulation (stage 12) (Fig. 6A). It is notable that xKazrinA expression increased as 
xKazrinB transcripts decreased between embryonic stages 18 and 40. 
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Figure 4. Sequence alignment of Xenopus laevis Kazrin  
 
Sequence alignment of Xenopus tropicalis Kazrin and two isoforms of human Kazrin 
(hKazrinA and hKazrinK). Identical and similar residues are highlighted in black or grey, 
respectively. The central coiled coil region (brackets), conserved potential leucine zipper 
and the predicted nuclear localization sequence (NLS) are indicated. 
      
 17 
A.  
 
 
 
 
 
 
 
 
B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Genomic structure of Xenopus tropicalis Kazrin and identification of two isoforms 
in X. laevis  
 
A) Genomic information was obtained from Ensembl database (Ensembl ID 
#ENSXETG00000013469 and scaffold 257). Asterisk (*) indicates an alternatively spliced 
exon in X. laevis. B) Identification of Xenopus laevis Kazrin isoforms using primers (F1 and 
R1) binding to the 5’- and 3’ - flanking region of exon 6. cDNA was synthesized from 
embryo stage 18 genomic RNA. Open arrowhead indicates PCR product of xKazrinB cDNA 
and closed arrowhead indicates that of xKazrinA.
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Figure 6. xKazrin expression during Xenopus development   
 
A) RT-PCR of xKazrin transcripts during development.  Primer set (F1+R1) was used to 
detect both xKazrin isoforms (top panel) and Histone H4 was used as a loading control 
(bottom panel). B) Equal amounts of Xenopus embryo lysates (0.5 embryo/lane) were 
resolved by SDS-PAGE and Western blotted for xKazrin (using IgG-purified anti-xKazrinA 
polyclonal antibody detecting the carboxyl terminal 200 amino acids), or GAPDH as a 
loading control (bottom panel). Non-specific signals were indicated as asterisks (*). 
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 To evaluate the temporal expression of xKazrin at the protein level, 
embryonic lysates were prepared from various developmental stages and subjected 
to Western blotting using an IgG-purified polyclonal antibody, which I raised against 
the carboxy terminal 147 aminos acids of xKazrinA. The predicted molecular 
weights of xKazrinA and B are 46.8 kDa and 50 kDa, respectively. However, a 50 
kDa band was not detected. Instead, 40 kDa, 47 kDa and 100 kDa appeared to be 
constitutively expressed from the oocyte to tadpole stage (Fig. 6B). Interestingly, the 
40 kDa and 100 kDa bands correspond to the size of human KazrinC/D isoform and 
Kazrin E isoform, respectively, implying existence of other Kazrin isoform in 
Xenopus. Since xKazrinA RNA was not detected until the blastula stage, the 
detected 47 kDa band was expected to be the xKazrinB isoform. However, it cannot 
be excluded that the KazrinA isoform might migrate to the same position in SDS-
PAGE and that these two proteins cannot be separated because ectopically 
expressed xKazrinA migrates at 47 kDa (data not shown).  
 
Expression of Kazrin in Xenopus adult tissues 
 When the same primer pairs were used to examine mRNA from adult 
tissues, xKazrinA expression was ubiquitous, whereas xKazrinB was expressed in 
some but not all tissues (Fig. 7A). Interestingly, these two isoforms were often 
inversely expressed; xKazrinB appeared to a lesser extent in adult tissues having 
high levels of xKazrinA.  
xKazrin proteins are variably expressed across tissues (Fig. 7B). Brain, 
heart, stomach, skin and lung contain a 47 kDa protein (maybe xKazrinA or B).  
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Figure 7. xKazrin expression in adult tissues 
 
A) RT-PCR of xKazrin transcripts from adult tissues. B) Western blot of SDS-soluble 
extracts from Xenopus adult tissues as indicated at the top.  xKazrin was detected as a 47 
kDa isoform (closed arrowhead, KazrinA or B), a 40 kDa isoform (open arrowhead, 
KazrinC/D) and a 97 kDa isoform (asterisk, KazrinE).  Equal amounts of total protein were 
loaded in each lane, and actin was detected as a relative loading control.  Molecular weight 
is indicated in kilodaltons (kDa).
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Brain expresses an additional 40 kDa xKazrin (xKazrinC/D) and even lesser 
amounts of a 40 kDa xKazrin appear in other tested tissues. 100 kDa xKazrin 
(xKazrinE) is abundantly expressed in the stomach.  Heart and muscle also express 
detectable levels of 100 kDa xKazrin. It is notable that brain, stomach and liver 
contain an xKazrin protein higher than 100 kDa. As a comparison, the same lysates 
were used to blot for ARVCF-catenin. ARVCF-catenin is expressed in all tissues 
except muscle. Although more study is required, this result may suggest that an 
interaction between ARVCF-catenin and Kazrin occurs in various adult tissues. 
Brain expresses multiple ARVCF proteins, which due to our previous findings about 
isoforms in Xenopus brain are expected to be different, alternatively spliced 
isoforms.  
 
Spatiotemporal expression pattern of xKazrin 
 The spatiotemporal expression patterns of xKazrin mRNA during 
development were studied using whole mount in situ hybridization (Fig. 8). xKazrin 
transcript is enriched in the animal pole region at the one-cell stage (Fig. 8A); in the 
dorsal neural fold and anterior future head region at neurula stages (Fig. 8B); and in 
the head region at tadpole stages.   
 
Prediction of xKazrinA coil structure 
 Previously we used the COILS program to predict that the central domain of 
xKazrin would form a coiled-coil region  
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Figure 8. Spatiotemporal expression pattern of xKazrin in X. laevis 
 
A) Kazrin whole mount in situ hybridization at one-cell stage embryos. B) Neurulation stage 
embryo in situ hybridization. C) Tadpole stage embryo in situ hybridization. Anti-sense Dig-
labeled RNA probe for full-length xKazrinA was used for whole mount in situ hybridization. 
As a negative control, the same amount of sense probe were used.
      
 24 
(http://www.ch.embnet.org/software/COILS_form.html) (80). Experimental results 
demonstrated that Kazrin binds to other proteins such as envoplakin, periplakin and 
ARVCF-catenin through a coiled-coil domain (73). Thus, the predicted structural 
information for xKazrin will assist us in testing models addressing how Kazrin’s 
putative coiled-coil domain engages in protein-protein interactions. To obtain high 
resolution structural information for Kazrin, we have been collaborating with Dr. 
Richard Brennan (UT MDACC) to do X-ray crystallography of xKazrinA. Prior to 
crystallography, using the given structural property of 3.5 amino acid residues per 
helical turn, I modeled the coil structures for xKazrinA.  I found five coiled-coils 
within xKazrin’s central region, and an additional coil (leucine zipper) in the amino 
terminal region (Fig. 9).   
 
Interaction between Kazrin isoforms 
 In order to check whether Kazrin isoforms bind each other, myc-tagged X. 
tropicalis Kazrin (similar to X. laevis KazrinB form) and HA-tagged X. laevis KazrinA 
were co-expressed in Xenopus embryos and their interaction was tested using co-
immunoprecipitation (co-IP). As shown in Fig. 10, two Kazrin proteins bind to each 
other. Because xKazrinA and xKazrinB are quite similar, Kazrin’s homophilic 
interaction is expected. For the binding site mapping, Kazrin deletion mutants were 
used in a co-IP experiment. I found that Kazrin proteins interact with each other via 
their coiled-coil region as expected (Fig. 11). 
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Figure 9. Predicted xKazrin coiled-coil structures   
 
A) Based upon direct study of the sequence regions in combination with the use of 
available software, xKazrinA was predicted to form as many as six amphipathic coiled coil 
structures with the indicated amino acid sequences (coiled coils by definition exhibit 3.5 
amino acid residues per helical turn). To aid in visualization, polar amino acid residues 
(asparagine (N), glutamine (Q), serine (S) and threonine (T)); nonpolar or hydrophobic 
amino acid residues (leucine (L), isoleucine (I), valine (V), alanine (A), methionine (M), 
phenylalanine (F)); acidic amino acid residues (aspartate (D), glutamate (E)) and basic 
amino residues (lysine (K), arginine (R)) are labeled and shaded in white, green, red and 
blue, respectively. Amino acid residues assigned to the “a” and “d” positions within the helix 
are most often nonpolar or hydrophobic and form a hydrophobic interface that favors 
interaction with a similarly nonpolar helical interface found within the same polypeptide 
(intramolecular interaction), or within another protein (intermolecular interaction: either 
homotypic or heterotypic).  B) The alignment of the amino acid sequences encompassing 
the six predicted coiled-coil regions reveals the periodic appearance of 
nonpolar/hydrophobic amino acid residues at the “a” and “d” positions. 
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Figure 10. Interaction between different xKazrin isoforms  
 
Xt-KazrinA (myc tagged) and Xl-KazrinA (HA tagged) were co-expressed in Xenopus laevis 
embryos. Lysates were immunoprecipitated for Myc-Xt KazrinA (A panel) or HA-Xl-KazrinA 
(B panel), and immunoblotted as indicated. 
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Figure 11. Binding domain mapping of Kazrin homo-dimerization  
 
A) Schematic diagram of xKazrin deletion mutants used in this study. The LZ indicates 
putative leucine zipper region. B) Indicated in vitro transcribed Kazrin deletion mutant RNAs 
were microinjected into one-cell stage embryos. Then early gastrula embryos were lysed 
and mutants were immuno-precipitated using Myc antibody, followed by SDS-
PAGE/western blotting. Asterisks (*) indicate non-specific signals from HA antibody western 
blotting. 
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Part Two : Cellular Localization of the ARVCF-catenin: Kazrin complex 
 
Cellular localization of xKazrinA 
 In mammalian cell lines and human skin tissues, Kazrin protein localizes at 
cell-cell contacts, in the cytoplasm and in the nucleus (74, 77). To determine 
xKazrin’s cellular localization in Xenopus tissues, I performed immunofluorescence 
using Xenopus blastula ectoderm (animal caps) (Fig. 12A). As endogenous xKazrin 
proved difficult to visualize by immunofluorescence using the Xenopus Kazrin 
antibody, I ectopically expressed Myc-tagged xKazrinA. In vitro transcribed Myc-
xKazrinA RNA was injected into one- cell stage embryos.  At the blastula stage, 
Myc-xKazrinA’s localization was examined in different cell layers within the 
ectoderm. Xenopus ectodermal (animal cap) tissue at this developmental time point 
consists of three to four cell layers; an outer layer that differentiates to epidermis 
and two to three inner cell layers. While most xKazrinA protein seems to be 
localized to cell-cell contacts within the outer cell layer and nuclear xKazrinA is also 
detected in some cells, inner cell layers displayed strong nuclear localization as well 
as cell-cell border localizations (Fig. 12B). Kazrin’s nuclear presence in Xenopus 
tissue is in accordance with its nuclear localization in cell lines and human skin. The 
weak nuclear signal in outer cell layers is thought to be due to difficulty in the 
penetration of the antibody through the outer cell membrane, because nuclear 
localization in outer cell layers was enhanced when a strong detergent was used 
during immunofluorescence to increase membrane permeability.  
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Figure 12. Cellular localization of xKazrin A in ectodermal explants of Xenopus blastula 
(stage 9-10) embryos  
 
A) Cross-sectional view of Xenopus blastula.  B) a) Myc-xKazrinA localization in the outer 
layer of the blastula ectoderm, detected using anti-Myc antibodies. b) Co-visualization of 
Myc-xKazrinA and nuclei (topro-3 dye) in the outer layer of blastula ectoderm. c) Myc-
xKazrinA localization in the inner layer(s) of blastula ectoderm. 
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xKazrinA and xARVCF co-localize at cell-cell contacts in Xenopus blastula 
ectoderm.  
 To assess HA-xARVCF and Myc-xKazrinA co-localization following co-
expression in vivo, immunofluorescent images were acquired from the outer 
ectodermal cell layer at blastula stages. Co-localization occurred along cell-cell 
borders in the X-Y plane (Fig. 13A-C), and to a significant extent, if not entirely 
along the Z-axis (Fig. 13D). In general, these findings are consistent with the 
biochemical association of xARVCF and xKazrinA. 
  
The xARVCF:xKazrinA complex is not a core component of adherens 
junctions or desmosomes.  
Since xARVCF directly binds cadherin juxta-membrane regions (41, 81, 82), I 
tested whether xKazrinA and xARVCF would co-localize with C-cadherin, a major 
cadherin essential for Xenopus early development (83, 84). Xenopus C (xC)-
cadherin co-localized at cell-cell borders with xKazrinA as well as with xARVCF 
(Fig. 13E-L), consistent with a possible association of xKazrinA with adherens 
junction components. 
To test if xKazrinA and xC-cadherin form a larger complex, presumably 
bridged by xARVCF, I over-expressed Myc-xKazrinA followed by xC-cadherin 
immunoprecipitation and Western blotting (Fig. 14). As anticipated, endogenous xC-
cadherin co-immunoprecipitated endogenous xARVCF, as well as x?-catenin and 
Xplakoglobin. Importantly, however, it did not co-precipitate Myc-xKazrinA. In further 
tests, I simultaneously over-expressed three components: HA-xKazrinA, HA- 
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Figure 13. Co-localization of xKazrinA with xARVCF and xC-cadherin in ectodermal 
explants of Xenopus blastula (stage 10) embryos   
 
A-D) Localization and co-localization of co-expressed Myc-xKazrinA and HA-xARVCF in the 
outer ectodermal layer, detected using anti-Myc and anti-HA antibodies respectively. The 
area outlined by a white rectangle in (C), was viewed using Z-stack section images shown 
in (D).  E-H) Localization and co-localization of HA-xARVCF and C-cadherin, detected 
respectively using anti-Myc and anti-C-cadherin antibodies.  I-L) Localization and co-
localization of Myc-xKazrinA and xC-cadherin. Bars = 50 mm. 
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Figure 14. Co-immunoprecipitation of Myc-xKazrinA with adherens junction components  
 
Myc-xKazrinA was expressed in early embryos, lysed at stage 9-10 and 
immunoprecipitated for endogenous xC-cadherin. Co-precipitated proteins were detected 
by immuno-blotting using the indicated antibodies. 
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xARVCF and the cytoplasmic tail of xC-cadherin (Myc-tagged).  Whereas xARVCF 
co-immunoprecipitated with C-cadherin’s cytoplasmic domain as expected, HA-
xKazrinA was not present in conjunction with cadherin (Fig. 15). These results 
indicate that xC-cadherin can form a complex with xARVCF but not with xKazrinA.  
Since human Kazrin associates with envoplakin and periplakin at 
desmosomal or inter-desmosomal regions in human keratinocytes (73), and 
ARVCF- and p120-catenins have been reported at desmosomes (85-88), I asked if 
ARVCF is present at desmosomes using biochemical precipitations from A431 
human epithelial carcinoma cell extracts and Xenopus embryos. In A431 cell 
extracts, endogenous Desmoglein1 (Dsg1) did not co-precipitate with human 
ARVCF while E-cadherin did (Fig. 16). Similarly, the cytoplasmic tail of human Dsg1 
(Fig. 17) or full-length mouse Dsg3 (Fig. 18) failed to co-precipitate with Xenopus 
ARVCF. Plakoglobin and xC-cadherin were positive controls for the respective 
binding functionality of Dsg1 and ARVCF in Xenopus embryos (Fig. 17). Our data 
indicate that xARVCF is not a core component of the desmosome.  
Furthermore, we could detect neither an interaction between xKazrinA and 
xC-cadherin, nor an interaction between xARVCF and xDsg1 under chemical cross-
linking conditions (DTSSP; 3,3’-Dithiobis Sulfosuccinimydilpropionate), while the 
interaction between xARVCF and xC-cadherin was increased as expected (positive 
control) (Fig. 19). This result supports the idea that the xARVCF:xKazrin complex is 
not a core component of the adherens junction.   
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Figure 15. Co-immunoprecipitation assay following the co-expression of Myc-xC-cadherin 
tail, HA-xARVCF and HA-xKazrinA  
 
Myc-xC-cadherin tail was precipitated using anti-Myc antibodies. Co-precipitated HA-
xARVCF and HA-xKazrinA were detected (versus not) using anti-HA antibody. Asterisk (*) 
indicates migration of IgG heavy chains (50 kDa). 
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Figure 16. Co-immunoprecipitation assay in A432 human carcinoma cells 
 
Endogenous Desmoglein 1 or E-cadherin was immuno-precipitated from confluent A431 
human epithelial carcinoma cells. Bound endogenous ARVCF was detected with human 
ARVCF specific antibody. As a negative control, mouse IgG was used for 
immunoprecipitation at the same time. 
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Figure 17. The interaction between desmosomal cadherin Desmoglein 1 and xARVCF in 
Xenopus embryo lysates  
 
Indicated amounts of in vitro transcribed RNAs were microinjected into one cell stage 
embryos. Then early gastrula embryos were lysed and human Desmoglein tail or xARVCF 
were immuno-precipitated, followed by SDS-PAGE/western blotting. 
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Figure 18. The interaction between mouse desmosomal cadherin Desmoglein 3 and 
xARVCF in Xenopus embryo lysates 
 
Indicated amounts of in vitro transcribed RNAs were microinjected into one-cell stage 
embryos. Then early gastrula embryos were lysed and mDesmoglein 3 or xARVCF were 
immuno-precipitated, followed by SDS-PAGE/western blotting. 
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Figure 19.  Chemical cross-liking usng the DTSSP (3,3’-Dithiobis 
Sulfosuccinimydilpropionate) chemical cross linker, followed by immuno-precipitation 
 
A) After cross-linking of embryo lysates expressing Myc-xKazrinA, lysates were subjected 
to SDS-PAGE/western blotting to check cross-linking status. Reversible DTSSP-induced 
chemical cross-links were cleaved using the reducing reagent, ?-mercaptoethanol.  B) 
Cross-linked lysates were precipitated using antibodies directed against ARVCF or C-
cadherin and co-precipitated proteins were detected with the indicated antibodies. 
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xKazrinA and xC-cadherin do not compete for xARVCF 
 Interestingly, the interaction between xKazrinA and xARVCF decreased as 
more xC-cadherin bound to xARVCF under cross-linking conditions, suggesting that 
xC-cadherin binding to xARVCF may be mutually exclusive with xKazrinA. In 
accordance with this, our previous binding domain mapping study demonstrated 
that both xC-cadherin and xKazrinA bind to the armadillo repeats of xARVCF-
catenin. 
 To test this hypothesis, I monitored the effects of xC-cadherin over-
expression on the xARVCF:xKazrinA interaction (Fig. 20), and the effect of 
xKazrinA over-expression on the xARVCF:xC-cadherin interaction (Fig. 21). 
Contrary to my expectation, I found that xC-cadherin and xKazrinA did not compete 
for binding to xARVCF.  
 Based on the cross-linking co-IP and competition IP experiments, I 
hypothesized the existence of two ARVCF complexes at the plasma membrane. 
First, the known presence of ARVCF at the adherens junction via cadherin 
association, and second, an ARVCF:Kazrin complex anchored to the plasma 
membrane by an unknown mechanism. In this model, ARVCF-catenin shuttles 
between these complexes, but the cadherin:ARVCF complex at adherens junctions 
is predominant. Thus, under chemical cross-linking conditions, ARVCF was reduced 
in its capacity to shuttle to Kazrin, lowering its detection in complex with Kazrin.    
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Figure 20.  Competition assay I 
 
 
A)  1ng Myc-xKazrinA RNA was micro-injected at the one-cell stage together with different 
amounts of HA-xC-cadherin RNA. The expression of each protein was detected from 
blastula embryo lysates using SDS-PAGE/immuno-blotting.  B) Endogenous ARVCF was 
precipitated from lysates described in (A), and co-precipitated xKazrinA and xC-cadherin 
were detected using Myc- and HA-antibodies, respectively.
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Figure 21.  Competition assay II 
 
 
After mixture of the indicated level of components, Myc-xKazrinA RNA and ?-gal RNA were 
micro-injected at the one cell stage, endogenous ARVCF was precipitated from late blastula 
embryo lysates (stage 10), and co-precipitated xKazrinA and xC-cadherin were detected 
using Myc- and C-cadherin specific antibodies, respectively. Expression of each protein 
was detected using SDS-PAGE/immuno-blotting. 
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xKazrin depletion decreases membrane localized xARVCF 
 It has been generally thought that cadherin proteins are the only significant 
membrane-binding partners of p120-catenin proteins, and thus that they determine 
the membrane localization of p120-catenin proteins. However, my results suggest 
that Kazrin may comprise another partner localizing ARVCF to cell-cell contacts. 
The effect of xKazrin on membrane localization of ARVCF was tested using a 
membrane fractionation assay (Fig. 22). Surprisingly, I found Kazrin depletion 
reduced membranous ARVCF-catenin protein and increased cytosolic ARVCF-
catenin slightly, suggesting that xKazrin may play a role in ARVCF-catenin retention 
at the plasma membrane. However, it cannot be precluded that the decrease of 
cadherin levels after Kazrin depletion (see Part III), indirectly freed ARVCF-catenin 
from the plasma membrane. 
 
xKazrinA binds to the x?2-spectrin cytoskeletal protein at cell-cell contacts  
 To further address how the xARVCF:xKazrinA complex localizes to cell 
contacts, I collaborated with Hybrigenics® to perform a yeast two-hybrid screening 
of xKazrinA. From an adult mouse brain cDNA library, we obtained 64 positive 
clones (partial list in Table 1).  Notably, 9 clones encoded plasma membrane-
associated proteins. These included two p120-catenin sub-family members (delta-
catenin and p0071), the tight junction protein symplekin (89), the spectrin binding 
protein Camsap1 (90, 91), and three spectrin family members (?1-, ?2- and ?2- 
spectrins) (92). This screen was not sensitive as we did not isolate ARVCF-catenin, 
envoplakin or periplakin, perhaps because ARVCF expression is lower in mammals  
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Figure 22.  Membrane fractionation assay after xKazrin depletion 
 
 
xKazrin depleted embryo lysates were prepared at late blastula stage (stage 10) and 
membrane fractionated. To control for complete fractionation, C-cadherin was detected for 
membrane fraction and actin for cytosolic fraction. Closed arrowhead indicates intact C-
cadherin and open arrowhead indicates cytosolic cleaved C-cadherin.  
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Table 1. Selected list of xKazrin interactors from yeast-two-hybrid screen  
Gene clones GenBank # Notes 
ARHGAP5 22 NM_009706.2 p190B RhoGAP  
Pkp4 10 NM_026361.2 p0071-catenin 
Ctnnd2 6 NM_008729.2 delta-catenin 
Spna2 1 NM_1076554.1 ?2-spectrin 
Spnb1 1 NM_013675.3 ?1-spectrin 
Spnb2 1 NM_175836.2 ?2-spectrin 
Camsap1 1 NM_001115076.1 calmodulin regulated  spectrin-associated protein 1 
Sympk1 1 NM_006605.2 symplekin 
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than amphibians (41), and because there is little envoplakin/ periplakin expression 
in neural tissues (93). 
 Spectrin as a potential Kazrin binding partner was intriguing given that our 
earlier structural analysis of xKazrinA with help of Dr. Richard Brennan predicted 
that its coiled-coil domain would be similar to the spectrin-repeat region of ?-
spectrin (GenThreader program in PSIPRED Protein Structure Prediction Server; 
http://bioinf.cs.ucl.ac.uk/psipred/; p-value = 4e-04) (94). In mammals, there are two 
?-spectrin genes and five ?-spectrin genes. Their gene products form ?? 
heterodimers that orient end-to-end to form ?2?2 tetramers. Tetramers in turn 
interact with microfilaments, neighboring spectrin tetramers and other proteins such 
as band 4.1, ankyrin, adducin and calmodulin, to form a multifunctional, cytoskeletal 
matrix (92). Anchoring points, such as provided by band 4.1 and ankyrin, facilitate 
the spectrin cytoskeleton’s plasma membrane association, as do junctional 
cadherins (92). In Xenopus, two spectrins are known, ?-spectrin (also known as ?-
fodrin) and ?-spectrin (95, 96). X?-spectrin expression, while high in oocytes, is 
reduced following fertilization (95). X?-spectrin mRNA on the other hand, is 
expressed throughout development as assessed via semi-quantitative RT-PCR (Fig. 
23). 
  I wondered if the spectrin network might be involved in the localization of 
xARVCF:xKazrinA to cell-cell borders. Confocal microscopy and biochemical 
approaches were employed using a partial X?2-spectrin cDNA (GenBank 
#BC046267.1). This construct is the longest available Xenopus ?-spectrin, and is 
homologous to human ?2-spectrin isolated from our yeast two-hybrid screen (74.6%  
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Figure 23. Xenopus ?2-spectrin mRNA expression during development  
 
Total RNA was isolated from embryos at the indicated stages, and RT-PCR was performed 
using a primer pair for Xenopus ?2-spectrin. Histone H4 served as a loading control.
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identical). It encodes ?2-spectrin’s N-terminal actin-binding domain (ABD ; which 
binds band 4.1 and adducin), and five spectrin repeats (Fig. 24). Isolation of shorter 
yeast clones from our two-hybrid screen suggested that the ?1- or ?2-spectrin 
regions extending from the end of the second spectrin repeat to the middle of the 
third repeat are sufficient to bind Kazrin (not shown). The xKazrinA:x?2-spectrin 
interaction was supported using co-precipitation tests of Xenopus embryo lysates in 
which full length xKazrinA and partial x?2-spectrin proteins were co-expressed (Fig. 
25). Furthermore, using confocal microscopy, I showed that xKazrinA and x?2-
spectrin co-localized to cell-cell borders in blastula ectoderm, as expected (Fig. 26).  
 
xARVCF, xKazrinA and x?2-spectrin form a ternary complex  
To test if x?2-spectrin binds to the xARVCF:xKazrinA complex in vivo, varying 
amounts of spectrin were expressed in Xenopus embryos with a constant amount of 
xKazrinA, and endogenous xARVCF complexes isolated and assayed (Fig. 27). As 
shown in Fig. 27, x?2-spectrin as well as xKazrinA were co-precipitated with 
xARVCF. As x?2-spectrin expression did not alter xARVCF:xKazrinA co-
precipitation, we expect that a ternary xARVCF:xKazrinA:x?2-spectrin complex was 
formed. However, since a prior study reported ?2-spectrin’s association with E-
cadherin (through ankyrin) (97), it was conceivable that xARVCF association with 
x?2-spectrin occurred via their mutual association with cadherin. 
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Figure 24. Comparison of Human and Xenopus ?2-spectrin cDNA 
 
A) Sequence alignment of human and Xenopus ?2-spectrin. Identical and similar residues 
are highlighted in grey. The actin binding domain (brackets), and the putative Kazrin binding 
domain (black box) suggested from our yeast two-hybrid screen are indicated.  B) 
Schematic comparison of human ?2 spectrin (gene bank ID # NM_003128) and Xenopus 
partial ?2 spectrin (BC046267) Actin binding domain (ABD) and putative Kazrin binding 
region are depicted. 
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Figure 25. In vivo binding of xKazrinA and x?2-spectrin  
 
Enzymatically synthesized Myc-xKazrinA and HA-x?2-spectrin mRNA were co-injected into 
one-cell stage embryos and blastula embryo lysates were HA immuno-precipitated followed 
by Myc immuno-blotted. 
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Figure 26. Co-localization of xKazrinA and x?2-spectrin in the blastula ectoderm  
 
Animal caps were isolated from blastula embryos (stage 9-10) expressing Myc-xKazrinA 
and HA-x?2-spectrin, followed by their respective (Myc and HA) immuno-fluorescent 
detection. 
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Figure 27. Formation of xARVCF, x?2-spectrin and xKazrinA ternary complex  
 
Blastula lysates from embryos injected with the indicated amounts of each mRNA were 
immuno-precipitated with xARVCF antibody, followed by immuno-blotting for Myc-xKazrinA 
and HA-x?2-spectrin. 
      
 56 
We tested this possibility using co-precipitation assays. As shown in Fig. 28, 
xARVCF but not xC-cadherin associated with x?2-spectrin and xKazrinA. Thus, the 
ARVCF:Kazrin complex likely associates with spectrin through Kazrin binding to 
spectrin.  
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Figure 28. ARVCF-specific ternary complex  
 
Lysates from blastula embryos expressing x?2-spectrin and xKazrinA were immuno-
precipitated using the indicated antibodies. Co-precipitating x?2-spectrin or xKazrinA were 
detected by immuno-blotting. 
      
 58 
Part Three : Cellular Role of the ARVCF-catenin:Kazrin complex 
 
Assessment of xKazrin morpholinos 
 In an effort to address the function of Kazrin in the Xenopus system, I used 
two independent morpholinos; one that blocks translation initiation of mature 
xKazrin mRNA (Kmo-T : Kazrin Morpholino targeting RNA Translation), and one 
that blocks nuclear processing of xKazrin pre-mRNA (Kmo-S: Kazrin Morpholino 
targeting RNA Splicing).  
 Kazrin depletion using the translation blocking morpholino in early Xenopus 
tropicalis embryos was previously reported to result in ectodermal blistering, a 
shortened body axis, head reductions, and somatic defects (78).  Because the 
mRNA sequence targeted by the morpholino used in X. tropicalis is completely 
conserved with that in X. laevis, I used it in my study (Kmo-T), and demonstrated its 
efficacy in blocking in vitro translation of Kazrin mRNA, and in knocking-down X. 
laevis Kazrin to 60% of endogenous levels by the neurulation stage (significant 
maternal protein loading precluded obtaining earlier effects) (Figs. 29A and B, 
respectively). 
 Kmo-S was designed to bind the 3’ end of exon 4 (Fig. 30A). RT-PCR 
analysis following morpholino injection revealed that Kazrin RNA expression was 
decreased in a dose-dependent manner (Fig. 30B). DNA sequencing of the product 
generated upon morpholino treatment (sequencing of the K1/ K2 PCR product) 
confirmed that exon 4 was skipped during splicing, producing a frame shift in exon 5 
followed by a non-sense mutation. 
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Figure 29. Assessment of xKazrin morpholino, Kmo-T   
 
A) In vitro translation blocking activity of xKazrin morpholino. In vitro transcribed xKazrinA 
and Myc-xKazrinA mRNAs were in vitro translated in the presence of Kmo-T or Cmo as a 
control. As expected, Kmo-T blocked the translation of xKazrinA mRNA and not that of 
Myc-xKazrinA, since the latter is an amino-terminal fusion product (w/ Myc) (thus offering 
incomplete sequence complementary with the morpholino targeting the endogenous 
xKazrinA translation initiation site).  B) xKazrin morpholino knock-down of endogenous 
xKazrin protein. Morpholinos were injected into one-cell stage embryos and lysates were 
prepared at neurulation (stage 18). Endogenous xKazrin (47 kDa) was detected by SDS-
PAGE/ immuno-blotting using polyclonal antibody raised against the carboxy-terminal 147 
amino acids of xKazrinA. Standard control morpholino (Cmo) was used as a negative 
control. 
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Figure 30. Assessment of xKazrin morpholino, Kmo-S   
 
A) Schematic diagram of morpholino binding region and primers used for testing 
morpholino activity (left panel). B) Effect of xKazrin morpholino S (Kmo-S) on expression of 
endogenous xKazrin RNA, assayed using RT-PCR. Embryos were injected with two 
different doses of Kmo-S (40 ng and 80 ng), total RNA was isolated from stage 18-19 
embryos, and RT-PCR was conducted using the indicated primer pairs.
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Kazrin depletion decreases cadherin protein levels and cell:cell attachment 
 My data showed that xKazrin depletion during X. laevis development induced 
loss of ectodermal integrity as reported in X. tropicalis (this phenotype will be 
detailed in Part four). To address the mechanism by which xKazrin depletion alters 
ectodermal integrity, I first considered effects upon C-cadherin and E-cadherin. 
Interestingly, both cadherins’ levels were decreased after xKazrin depletion using 
either Kmo-T (Fig. 31) or Kmo-S (Fig. 32), as was that of Desmoglein 1, a 
desmosomal cadherin (Fig. 33). As a control, endogenous Kazrin protein was 
detected using a specific antibody, with Fig. 31 showing that Kazrin protein was 
decreased about 30% following Kazrin depletion, which is similar to an about 40% 
decrease in the previous experiment (Fig. 29). A previous report employing cell 
lines in combination with immunofluorescence methods indicated that Kazrin over-
expression lowers desmoplakin and perhaps E-cadherin levels (77). This suggests 
that Kazrin plays a role in the stability of junctional proteins.  
 To evaluate xKazrin depletion effects upon cell:cell adhesion in a more 
controlled setting, I performed cell dissociation and cell re-aggregation assays using 
blastula ectoderm tissue (animal caps). xKazrin-depleted tissue exhibited 
accelerated dissociation compared to controls even without EGTA which weakens 
cadherin-mediated cell contacts (Fig. 34), and correspondingly, they experienced 
delayed re-aggregation (Fig. 35). Together, our data suggest that Kazrin positively 
modulates cell:cell contacts and affects cadherin levels.  
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Figure 31. The effects of xKazrin depletion using Kmo-T upon cadherin and catenin protein 
levels 
 
Decrease of cadherin and catenin protein levels after xKazrin depletion. Embryos injected 
at the one-cell stage with different amounts of the indicated morpholinos were lysed at the 
early gastrula (stage 10) and neurula (stage 18) stages. Indicated protein levels were 
visualized by immuno-blotting. 
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Figure 32. The effects of xKazrin depletion using Kmo-S on cadherin and ARVCF-catenin 
 
 
Decrease of cadherin and ARVCF-catenin protein levels after xKazrin depletion using Kmo-
S morpholino. Embryos injected at the one-cell stage with different amounts of the indicated 
morpholinos were lysed at the early gastrula (stage 10) stage. Indicated protein levels were 
visualized by immuno-blotting. 
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Figure 33. The effects of xKazrin depletion on desmosomal cadherin, desmoglein 1  
 
 
Embryos injected at the one cell stage with two different amounts of the indicated 
morpholinos were lysed at the neurula (stage 18) stage. Desmoglein 1 protein levels were 
visualized by immuno-blotting using a specific antibody. As a positive control, classical 
cadherins levels were visualized, too. 
 
      
 66 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34. Cell dissociation assay using animal cap explants  
 
Blastula ectoderm (animal caps; stage 9-10) from embryos injected with control (Cmo), 
Kazrin morpholino T (Kmo-T) or ARVCF morpholino 1 (ARVmo-1) were dissociated in the 
absence (upper panel) or presence of 2 mM EGTA (lower panel). Photos were taken at 0hr, 
1 hr and 2 hr following EGTA addition. 
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Figure 35. Cell re-aggregation assay using animal cap explants 
 
 
Inner cells of blastula ectoderm (animal caps; stage 9-10) from embryos injected with 
control (Cmo) or Kazrin morpholino T (Kmo-T) were isolated and dissociated in Ca, Mg-free 
medium. Then, cells were re-aggregated in the presence of 2 mM CaCl2.  Photos were 
taken at 2 hr following CaCl2 addition.
      
 68 
Kazrin depletion decreases catenin proteins levels 
 As for cadherin, the level of xARVCF, Xp120 and x?-catenin decreased in 
response to xKazrin depletion (Figs. 31 and 33). One possible explanation for 
Kazrin’s modulation of cadherin protein levels is its above-shown relationship with  
ARVCF. Based upon published reports, lowered ARVCF levels, as for lowered p120 
levels, are expected to result in lowered cadherin levels (21-24). To test whether 
xKazrin affects cadherin levels through regulation of xARVCF, the levels of 
cadherins and catenins were examined after xARVCF depletion (Fig. 36). Whereas 
classical cadherin levels were down-regulated by xARVCF depletion as expected, 
desmoglein 1 and p120-catenin levels were not changed. This result suggested that 
xKazrin-mediated regulation of ARVCF-catenin stability may not be a main cause of 
decreased levels of various cadherins and catenins after xKazrin depletion. One 
alternative model is that cadherin levels are reduced after xKazrin depletion by an 
unknown mechanism and then catenins are destabilized because lowered cadherin 
presence can result in reduced catenin levels (e.g. beta-catenin)(13, 98).  
 It is notable that one xARVCF morpholino did not reduce cadherin levels 
although endogenous xARVCF-catenin levels were reduced (Fig. 36). The reason 
for this discrepancy will require further investigation. 
 
Kazrin depletion leads to increased RhoA activity and cortical actin 
disorganization. 
One unanswered question revolves around how xKazrinA, or the 
xARVCF:xKazrinA complex, modulates cadherin stability. p120 sub-family catenins  
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Figure 36. The effects of xARVCF depletion on cadherin and catenin expression 
 
 
Embryos were injected at the one cell stage with two independent morpholinos and lysates 
were prepared at the neurula (stage 18) stage. Indicated protein levels were visualized by 
immuno-blotting. 
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including ARVCF are thought to stabilize cadherins by binding cadherin membrane-
proximal domains to reduce protein associations (such as Hakai or presenilin-1) 
(49, 51, 59) or modifications promoting cadherin degradation/ endocytosis (21, 23, 
24). Rho GTPases that are modulated by p120 sub-family catenins are further 
relevant to cadherin stabilization/endocytosis (26, 57, 70, 71, 99-101). Interestingly, 
a previous non-biased screen correlated Kazrin over-expression with inhibition of 
clathrin-mediated endocytosis of the transferrin receptor (76). Thus, Kazrin, together 
with p120 sub-family catenins, may be relevant to cadherin endocytosis. Indeed, 
cadherin levels after Kazrin depletion were restored when embryos were incubated 
with a specific dynamin inhibitor (Dynasore; Fig. 37) (102), and ectodermal defects 
induced by Kazrin depletion were partially rescued (data not shown). This suggests 
a potential role for Kazrin in cadherin endocytosis. 
 None the less, given known ARVCF- (and p120-) catenin effects upon small 
GTPases (22, 61-63), I turned my attention to xKazrinA effects on RhoA and Rac, 
and on cortical actin organization in plasma membrane regions. I initially evaluated 
RhoA activity in embryos following the depletion of xKazrin and/or xARVCF (Fig. 38). 
Interestingly, xKazrin depletion significantly increased RhoA activity, an effect 
likewise observed (and expected) following xARVCF knock-down (22). Coordinate 
xKazrin and xARVCF depletion had an additive effect upon RhoA activity. As Rac1 
was not affected by xKazrin depletion (data not shown), Kazrin may be a RhoA 
specific modulator. My results are in line with a report indicating that Kazrin over-
expression inhibits RhoA in human keratinocytes, with no apparent effect on Rac1 
(77). Thus, while Kazrin and xARVCF appear to have shared inhibitory effects upon  
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Figure 37.  Effect of inhibiting clathrin-mediated endocytosis on the reduced xE-Cadherin 
levels observed following xKazrin depletion  
 
One cell stage embryos were injected with the indicated morpholinos. Embryos were 
subsequently (32-64 cell stages) incubated with 50mM Dynasore (versus DMSO solvent). 
Lysates from neurula (stage 18) embryos were immuno-blotted for xE-cadherin and 
GAPDH. 
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Figure 38.  Rho activity in response to xARVCF and/ or xKazrin depletion  
 
 
The indicated morpholinos were injected into one cell stage embryos, and lysates from late 
blastula (stage 9-10) embryos were tested for RhoA activity in vitro. 
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RhoA, one distinction (relative to ARVCF and related p120 sub-family members) is 
that Kazrin is not likely to modulate Rac1 in this context (22, 61-63).  
  Since ectopic RhoA activation modulates actin and cell structure/ 
morphology (103), I employed phalloidin staining to grossly resolve the effects of 
Kazrin depletion on actin organization in embryos (Fig. 39). Whereas control 
embryos exhibited a defined enrichment of cortical actin at cell:cell borders, Kazrin 
depleted embryos displayed a disorganized pattern, and an actin signal of reduced 
thickness along the Z-axis. The cytoskeletal disorganization resolved in vivo 
appears to be in keeping with a previous report employing keratinocytes (77). To 
test whether increased RhoA activity after Kazrin depletion contributes to cadherin 
destabilization, different forms of RhoA and Rac1 were ectopically expressed and 
E-cadherin levels were monitored. As expected, active RhoA specifically decreased 
E-cadherin levels (Fig. 40). In summary, Kazrin appears to be a negative regulator 
of RhoA in vivo, suggesting that increased RhoA activity on Kazrin depletion 
contributes to microfilament reorganization, and possibly to lowered cadherin levels 
as previously published (70, 99).  
 
xKazrinA interacts with Xp190B RhoGAP.  
 I wondered if Kazrin might modulate RhoA via another protein(s), since 
predictive analysis suggested it was unlikely to directly bind RhoA. Common 
modulators of RhoA include RhoGDIs (Rho GDP Dissociation Inhibitors), RhoGAPs 
(Rho GTPase Activation Proteins) and RhoGEFs (Rho Guanine nucleotide 
Exchange Factors). Intriguingly, from the xKazrinA yeast two-hybrid screen, I  
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Figure 39. Actin staining of blastula ectoderm after Kazrin depletion  
 
 
Animal caps were isolated and filamentous actin in deep (inner) cells were visualized using 
phalloidin-Alexa 488 fluorescence. 
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Figure 40. The effects of Rho GTPases on E-cadherin levels 
 
The indicated mutant RhoA and Rac1 RNAs were micro-injected into one cell stage 
embryos and embryos were later lysed at the blastula stage (stage 10). E-Cadherin levels 
were visualized by SDS-PAGE/Western blotting. GAPDH was detected as a loading 
control. 
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identified multiple independent clones of mouse p190B RhoGAP (Table 1). This 
novel Kazrin interaction suggested one means by which it might influence RhoA 
activity and function. 
 There are two p190 RhoGAPs, p190A and p190B, and both are widely 
functioning negative regulators of Rho GTPases (104). Recently, p120-catenin was 
shown to mediate RhoA inhibition via the recruitment of p190A RhoGAP (105, 106). 
This suggested that xARVCF-catenin might analogously associate with p190B, 
bridged or facilitated by Kazrin. Upon analysis of our yeast two-hybrid findings 
(alignment of limiting sequences from 22 independent clones), I deduced that 
xKazrinA binds to a region within or spanning the 3rd-4th FF domains of p190B, an 
?-helical structure including two conserved phenylalanine residues at the end of the 
N- and C-termini (Figs. 41 and 42) (107). Interestingly, this portion of p190 RhoGAP 
also associates with activated Rac1 and Rnd3 (Rnd3 being a constitutively active 
RhoA antagonist), leaving open the possibility that Kazrin association with p190 
RhoGAP may be competitive with that of Rac1 and Rnd3 (108, 109). 
 To further test the validity of Kazrin’s interaction with p190B, I performed co-
IP experiments from embryo extracts and used pull-down experiments with GST-
purified-components, using human p190B as well as the longest available (partial) 
Xenopus p190B construct (79% sequence identity with human) (Figs. 41 and 42). 
Following expression in vivo, both full-length human p190B and partial Xp190B 
construct robustly co-immunoprecipitated with xKazrinA (Fig. 43), and they co-
localized to cell:cell borders (Fig. 44). Finally, in a reductionist context, GST-xKazrin  
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Figure 41. Schematic comparison of Human and Xenopus p190B   
 
 
Identical and similar residues are highlighted in grey. The GTPase domain (brackets), 
RhoGAP domain (black box), and Kazrin binding domain (shaded box), were suggested 
based upon published literature for p190A or p190B RhoGAP, or our yeast two-hybrid 
results.
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Figure 42. Schematic comparison of Human p190B (GeneBank ID # NM_001030055) and 
Xenopus p190B (BC084299.1)  
 
Protein domains were predicted using the SMART website (http://smart.embl-
heidelberg.de/). The predicted binding region of Rnd proteins and Kazrin is shown. 
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Figure 43. Interaction of xKazrinA with Xp190B 
 
 
A) In vivo binding of xKazrinA to Xenopus p190B. The indicated mRNAs were injected into 
one-cell embryos. Immuno-precipitates of HA-tagged proteins were obtained from early 
gastrula (stage 10-11) extracts, followed by immuno-blotting for Kazrin (Myc antibody). B) In 
vivo binding of xKazrinA to human p190B. Myc-Kazrin was precipitated from embryo 
lysates expressing indicated proteins, followed by immuno-blotting for p190Bs. 
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Figure 44. Co-localization of xKazrinA and Xp190B in blastula ectoderm  
 
Blastula ectoderm (stage 9-10) co-expressing Myc-xKazrinA and HA-Xp190B was isolated, 
fixed and visualized by confocal fluorescent imaging for Myc and HA. 
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was co-precipitated with in vitro translated p190B suggesting their direct interaction 
(Fig. 45).  
 Given their physical association, I asked if the xKazrinA:p190B interaction 
might be functionally evident in cadherin stability. E-cadherin levels decreased upon 
 Kazrin depletion and were restored by ectopic expression of human p190B 
RhoGAP (Fig. 46), consistent with the possibility that lowered cadherin levels in 
Kazrin knock-down embryos might result from abnormal activation of RhoA.   
   To investigate if xKazrin might facilitate p190B association with xARVCF, I 
asked if Kazrin expression had an impact upon p190B’s association with xARVCF. 
As indicated in Fig. 47 (lane 3), a trace but reproducible amount of p190B was 
detected in a complex with ARVCF only upon Kazrin co-expression. I next turned to 
in vitro pull-down assays to evaluate how p190B might associate with ARVCF (Fig. 
48). As expected, based upon the precipitations from Xenopus extracts, in vitro 
translated Xp190B was pulled down with MBP-xARVCF in the presence of GST-
xKazrinA (lane 3). This suggests that these three proteins form a ternary complex. 
Even in the absence of xKazrinA, Xp190B appeared to weakly bind xARVCF (lane 
1). Thus, while requiring later study, it appears that Kazrin may recruit and/or 
enhance p190B association with ARVCF. In all cases, our data supports xKazrin’s 
direct association and functional interaction with Xp190B RhoGAP. 
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Figure 45. In vitro binding assay involving xKazrinA and Xp190B  
 
In vitro transcribed and translated Xenopus p190B RhoGAP protein was subjected to GST 
pull down using bacterially purified GST-xKazrinA protein. Bacterially purified GST served 
as a negative control. 
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Figure 46. Ectopic p190B rescues xE-Cadherin levels, reduced following xKazrin depletion  
 
 
The indicated morpholinos and mRNAs were injected into one cell embryos. Neurulation 
(stage 18) extracts were immuno-blotted as indicated. 
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Figure 47. In vivo ternary complex formation of xARVCF:xKazrinA:Xp190B  
 
Extracts from gastrula stage embryos expressing the indicated proteins and endogenous 
xARVCF were precipitated for xARVCF. Co-precipitated xKazrinA and Xp190B were 
detected using antibodies respectively directed against Myc and HA. 
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Figure 48. In vitro ternary protein complex of xARVCF:xKazrinA:Xp190B 
 
In vitro transcribed and translated Xp190B was incubated with bacterially purified GST-
xKazrinA and MBP-xARVCF. Pull-down of xARVCF occurred using amylose-agarose 
beads, followed by immuno-blotting as indicated. 
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Part Four : Developmental Roles of the ARVCF-catenin:Kazrin complex 
 
Function in Ectoderm Integrity 
 
Morpholino depletion of xKazrin results in disruption of tissue integrity 
 Morpholino-directed Kazrin depletion in early Xenopus tropicalis embryos 
was previously reported to result in ectodermal blistering, shortened body axis, 
head reductions and somatic defects (78). The phenotypes appearing in X. laevis 
were similar to those previously indicated in X. tropicalis. Like embryos injected with 
standard-control morpholino (Cmo), those injected with xKazrin morpholinos (Kmo-
T or Kmo-S) did not produce gross morphological changes through gastrulation 
(data not shown). However, xKazrin depletion with Kmo-T morpholino (which has 
the same sequence as the morpholino used in X. tropicalis) in X. laevis appeared to 
have a severe impact on the ectoderm, as evident in abnormal neural tube closure 
during neurulation, and in regional ectoderm shedding in addition to blistering at 
early tailbud stages (Fig. 49A). The fraction of embryos exhibiting such phenotypes 
increased in a dose dependent manner (Fig. 49B and Table 2). As I obtained the 
same results using an independent Kmo-S morpholino in X. laevis, the specificity of 
our phenotype was supported (Fig. 50). During neurulation, embryos micro-injected 
with Kmo-S began to exhibit varying extents of defects in neural fold closure (Fig. 
50A a-a’), neural fold formation (Fig. 50A b-b’), and ectodermal integrity (Fig. 50A c-
c’). Overall, greater than 80% of Kmo-S injected embryos (40 or 80 ng doses) 
displayed these overt phenotypes (Fig. 50B and Table 2). 
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Figure 49. Reduced ectoderm integrity results following xKazrin morpholino-T injection 
 
A) Embryos at the one-cell stage were microinjected with the indicated morpholinos, and 
embryos were evaluated at neurulation (stage 18) and early tailbud stages (stage 20). B) 
Dose-dependent effect of Kmo-T morpholino on ectoderm integrity. Two doses of xKazrin 
morpholino (Kmo-T) were injected into one-cell stage embryos, and embryos having 
defective ectoderm were counted at tailbud stages (stages 20-22). Bar graph shows the 
average value of three independent experiments. 
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Figure 50. Reduced ectoderm integrity results following xKazrin morpholino-S injection 
 
 
A) Stage 19-20 embryos are shown following Kmo-S (a’, b’ and c’) versus standard-control 
morpholino (a, b, and c) injections into the animal region of one cell stage embryos, or into 
both cells of two-cell stage embryos. B) Bar graph indicates the percentage of defective 
embryos following xKazrin depletion. 
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Morpholino   or  RNA                       Embryos (N)          Normal (%)          Defective (%)                 Expt. 
80 ng Standard Control morpholino        186                        94                            5                   5       
40 ng xKazrin morpholino – S          78                         12                          88                               2 
80 ng xKazrin morpholino – S                  138                         6                            94                               4 
40 ng Standard Control morpholino         245                        98                            1                                5 
20 ng xKazrin morpholino - T                   297                        44                           56                               5 
40 ng xKazrin morpholino - T                   223                         4                            89                               5  
Uninjected                                                128                       100                           0                                4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Summary of xKazrin depletion 
 
Xenopus embryos were injected with xKazrin morpholinos at the one cell stage, and scored 
at stage 18-20 for defects in proper neural tube formation and ectoderm shedding. This 
table shows the combined results from multiple experiments. 
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 Intriguingly, both in our and others’ hands (78) (data not shown), Kazrin over-
expression in Xenopus does not generate an obvious phenotype(s). While 
speculative, it is possible that effects occur but are more effectively compensated 
for in vivo than in vitro.  
 
xARVCF partially rescues embryonic phenotypes resulting from xKazrin 
depletion.  
 To test for an in vivo functional interaction between xARVCF and xKazrinA, I 
attempted to rescue ectodermal shedding through ectopic expression of xARVCF 
(Fig. 51 and Table 3). As shown in Fig. 51B, Kazrin depletion was partially rescued 
by an appropriately titrated dose of ectopic xARVCF (dose sub-phenotypic in 
isolation), consistent with xKazrin:xARVCF functional interactions in maintaining 
ectodermal integrity.  
 
xC-cadherin and p190B Rho GAP rescues embryonic phenotypes resulting 
from xKazrin depletion 
 From the study of cellular function in part three, I concluded that the ARVCF-
catenin:Kazrin complex modulates RhoA via p190B RhoGAP and subsequent RhoA 
activity regulates cadherin endocytosis and stability. To evaluate this, I used 
phenotypic rescue of ectodermal shedding in embryos depleted of xKazrin as a 
read-out.  
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Figure 51. Rescue of ectoderm integrity, reduced upon xKazrin depletion, through ectopic 
expression of xARVCF   
 
A) The indicated morpholinos and mRNAs were co-injected into one cell stage embryos. 
After vitelline membrane removal, representative tailbud stage embryos were imaged 
(stages 20-22).  B) Graphical depiction of xARVCF rescue of xKazrin depletion effects upon 
ectoderm integrity. Two concentrations of xARVCF mRNA were used in the rescues, with 
similar results being observed from four independent experiments. 
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Table 3.  xARVCF rescue of xKazrin depletion 
 
The indicated mixture of morpholino and RNA was micro-injected into one-cell stage 
embryos. Then, embryo phenotypes were observed and counted at tailbud stages (stage 
20-22). The table represents a summary of multiple independent experiments. Dead 
embryos without a loss of ectoderm integrity were also included in the total number (N). 
Injection Number of embryos 
morpholino RNA total (N) normal 
loss of tissue 
integrity  
# expts. 
20 ng CMO  100 pg ?-gal 127 123 2 4 
20 ng KMO1 100 pg ?-gal 132 26 97 4 
20 ng KMO1  20 pg xARVCF + 80 pg ?-gal 122 67 43 4 
20 ng KMO1 100 pg xARVCF 138 75 61 4 
20 ng CMO  100 pg xARVCF 72 69 3 2 
uninjected uninjected 94 94 0 4 
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 Considering the outcome of dissociation/re-aggregation assays (Fig. 34 and 
35), together with biochemical evidence (Fig. 31, 32 and 33), the observed 
reduction of ectoderm integrity (Fig. 49 and 50) is likely due to reduced cadherin 
levels following xKazrin depletion. Thus, I first tested whether ectopic expression of 
xC-cadherin rescued this loss of ectoderm integrity after xKazrin depletion. 
Defective phenotypes were partially rescued upon ectopic expression of an 
appropriately titrated dose of C-cadherin (sub-phenotypic in isolation) as shown in 
Fig. 52 and Table 4, supporting the function of ARVCF:Kazrin complex in cadherin 
stability.  
 Since RhoA activation might have contributed to the ectoderm fragility we 
observed following Kazrin depletion, I tested the rescuing capacity of carefully 
titrated dominant-negative RhoA (versus dominant-active RhoA), upon co-injection 
with Kazrin morpholino (Kmo-T). In line with RhoA being functionally relevant and 
possibly downstream of Kazrin, co-injection of DN-RhoA mildly rescued observed 
phenotypes, while titrated DA-RhoA doses only worsened developmental defects 
(data not shown). 
 Finally, shedding phenotypes were partially but significantly rescued by 
titrated amounts of ectopic p190B (human full-length), and this occurred in a dose-
dependent manner (Fig. 53 and Table 5). These results support the concept that 
p190B and Kazrin are functionally coupled. 
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Figure 52. Rescue of ectodermal integrity, reduced upon xKazrin depletion, through 
expression of xC-Cadherin  
 
Embryos injected with the indicated morpholino and mRNA were assessed for ectoderm 
shedding at tailbud stages (stage 20-22). 
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Table 4. xC-cadherin rescue of xKazrin depletion 
 
Experiment was performed as described in Fig. 52. Table shows combined results of three 
independent experiments.  
 
 
 
 
 
Injection Number of embryos 
morpholino RNA total (N) normal 
loss of tissue 
integrity  
# 
expts. 
20 ng CMO  100 pg ?-gal 89 88 1 3 
20 ng KMO1 100 pg ?-gal 77 18 59 3 
20 ng KMO1  100 pg HA-xC-cadherin 81 37 44 3 
20 ng CMO  100 pg HA-xC-cadherin 85 85 0 3 
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Figure 53. Partial rescue of ectoderm integrity, reduced following xKazrin depletion, upon 
expression of human p190B (Hp190B)  
 
Embryos were injected with the indicated amounts of morpholino and mRNA at the one cell 
stage. Ectoderm integrity was evaluated at tailbud stage (stage 20-22) in three independent 
experiments. 
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Table 5. Hp190B rescue of xKazrin depletion 
 
Experiment was performed as described in Fig. 53. Table shows the combined results of 
three independent experiments. Dead embryos without loss of ectoderm integrity were 
included in the total number (N).  
Injection Number of embryos 
morpholino RNA total (N) normal 
reduced tissue 
integrity  
# 
expts. 
20 ng Cmo  500 pg ?-gal 104 99 1 3 
20 ng Kmo-T 500 pg ?-gal 75 10 65 3 
20 ng Kmo-T  100 pg Hp190B + 400 pg ?-gal 91 22 69 3 
20 ng Kmo-T 500 pg Hp190B 92 46 46 3 
20 ng Cmo  500 pg Hp190B 70 70 0 3 
uninjected uninjected 81 81 0 3 
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Function in Craniofacial Development 
 
xKazrin depletion in the head region induces eye and craniofacial 
developmental defects 
 Whole mount in situ hybridization revealed that Kazrin mRNA is expressed in 
the head region of tailbud embryos (Fig. 8) and comparable amounts of various 
Kazrin isoform proteins are detected in adult brain tissue (Fig. 7). Together with 
earlier cloning of Kazrin from a mouse brain cDNA library, these results suggested 
Kazrin’s specific role during head or brain development (72). To address this 
possibility, xKazrin was specifically depleted in the future head region by injecting 
xKazrin morpholinos (Kmo-T and Kmo-S) into the animal region of one dorsal 
blastomere at the four cell stage. As shown in the bottom panels of Fig. 54, the eye 
was smaller in the xKazrin-depleted side (right side) and in addition, the head axis 
was distorted to the right side. Careful observation suggested that the axis kink was 
due to a smaller head size in the xKazrin morpholino-injected side. This effect was 
specific to dorsal animal depletion compared to ventral vegetal depletion as a 
control (Fig. 55). The specificity of xKazrin depletion was demonstrated by the 
rescue of defects using ectopic expression of xKazrinA (Fig. 56 and Table 6).  
 
xARVCF depletion in the head region induces eye and craniofacial 
developmental defects 
 Since xARVCF is a binding partner of xKazrin and since specific Xp120-
catenin depletion in the head region was reported to result in eye and craniofacial  
      
 101 
 
 
Figure 54. Eye and craniofacial defects after xKazrin or xARVCF depletion in the dorsal 
animal region  
 
xKazrin or xARVCF morpholinos were micro-injected into the animal region of one dorsal 
blastomere at the four cell stage. Embryos were fixed with MEMFA buffer and pictures were 
taken at the tadpole stage (stage 43). The white dotted line indicates the middle of the 
embryo head. Injected sides were stained pink due to co-injection of ?-gal RNA, which was 
detected by Red-gal staining.  
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Figure 55. Injection region specific effects of xKazrin depletion 
 
Kmo-S morpholino was micro-injected into either the animal region of one dorsal 
blastomere or the vegetal region of one ventral blastomere. Pictures of the embryos were 
captured at the tadpole stage.
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Figure 56.  xKazrinA rescues craniofacial defects after xKazrin depletion 
 
In vitro transcribed xKazrinA mRNA was co-injected with Kmo-S morpholino into the dorsal 
animal region of four cell stage embryos. Embryo phenotypes were investigated and 
counted at the tadpole stage (stage 43).  
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Table 6.  Rescue of craniofacial defects from xKazrin depletion with ectopic expression of 
xKazrinA  
 
Experiments were performed as described in Fig. 56.
Injection Number of embryos 
morpholino RNA total (N) normal 
craniofacial 
defects  
# 
expts. 
20 ng Cmo  500 pg ?-gal 45 45 0 2 
20 ng Kmo-S 500 pg ?-gal 47 5 42 2 
20 ng Kmo-S  500 pg myc-xKazrinA 46 21 25 2 
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defects similar to xKazrin depletion (110), the effects of xARVCF depletion in head 
region was tested in parallel (Fig. 54). As expected, xARVCF depletion also induced 
eye and craniofacial defects, suggesting shared role of xARVCF and xKazrin during 
Xenopus head development. 
 
xARVCF partially rescues the eye and craniofacial defects from xKazrin 
depletion 
 To test the functional interplay between xARVCF and xKazrin during 
Xenopus eye and craniofacial development, I performed rescue experiments with 
sub-phenotypic levels of xARVCF (Fig. 57). Notably, xARVCF can rescue eye and 
craniofacial defects as much as similar amounts of xKazrinA (Fig. 57B and Table 7), 
implying that the xARVCF-catenin:Kazrin complex plays a role in Xenopus head 
development.  
 
xKazrin and xARVCF depletion induces malformation of the craniofacial 
cartilage 
 To check craniofacial defects of abnormally developed Xenopus skulls after 
xARVCF-catenin or xKazrin depletion, cartilage from embryos that were injected 
with each morpholino were investigated after alcian blue staining. As shown in Fig. 
58, depletion of either xARVCF or xKazrin by morpholino induced 
underdevelopment of both ceratohyal cartilage and ceratobranchial cartilage as 
compared to the normal cartilage seen in the un-injected side. 
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 107 
 
 
 
Figure 57. xARVCF as well as xKazrinA partially rescue craniofacial defects from xKazrin 
depletion 
 
Mixtures of the indicated morpholinos and in vitro transcribed RNA were micro-injected into 
the animal region of a one dorsal blastomere at the four cell stage. Embryos were allowed 
to develop at 18°C until the tadpole stage after which the phenotypes were observed and 
counted. Pictures were taken of representative embryos (A) and results are graphically 
presented in B. 
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Table 7. Rescue of the craniofacial defects from xKazrin depletion with ectopic expression 
of xARVCF and xKazrinA 
 
 
Experiment was performed as described in Fig 57.  
Injection Number of embryos 
morpholino RNA total (N) normal craniofacial defects  
# 
expts. 
10 ng Cmo  100 pg ?-gal 86 78 6 3 
10 ng Kmo-S 100 pg ?-gal 87 31 55 3 
10 ng Kmo-S  100 pg xARVCF 85 47 37 3 
10 ng Kmo-s 100 pg xkazrinA 67 33 24 3 
uninjected uninjected 79 75 0 3 
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Figure 58. Developmental defects of Xenopus skull cartilage after xKazrin or xARVCF 
depletion 
 
After embryos were injected with the indicated morpholinos at the four cell stage, tadpoles 
(stage 43) were fixed and cartilage was stained with Alcian blue dye. Asterisks (*) indicate 
the morpholino-injected side. CH: ceratohyal cartilage; CB: ceratobranchial cartilage. 
* * * 
CH 
CB 
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xKazrin or xARVCF depletion decreased detection of migrating neural crest 
cells 
 Since the craniofacial skeleton originates from neural crest cells (NCC) (111), 
it is possible that xARVCF-catenin:xKazrin complex play a role in NCC development. 
As expected, whole mount in situ hybridization with twist neural crest marker 
revealed that depletion of xKazrin or xARVCF decreased all three streams of NCC; 
branchial, hyoid and mandibular NCCs (Fig. 59). This result is consistent with the 
developmental defects of ceratohyal cartilage and ceratobranchial cartilage, which 
originate from hyoid NCCs and brachial NCCs, respectively (Fig. 58). A defect of 
Meckel’s cartilage from mandibular NCCs was also observed in the xKazrin or 
xARVCF depleted side. Interestingly, it was previously reported that abnormal 
activation of RhoA inhibits NCC establishment in Xenopus (112). Therefore, 
ARVCF-catenin:Kazrin complex may affect NCC establishment by modulating 
RhoGTPase activity.   
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Figure 59.  Twist in situ hybridization after xKazrin- or xARVCF-depletion 
 
The indicated morpholinos were injected into the animal region of one dorsal blastomere at 
the four cell stage. At the neurula stage (stage 19) embryos were fixed and neural crest 
cells expressing twist mRNA were visualized using whole mount in situ hybridization. 
Asterisks (*) indicate the injected side. Br: Brachial neural crest cells; H: Hyoid neural crest 
cells; M: mandibular neural crest cells. 
 
M 
H 
Br 
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CHAPTER III 
 
DISCUSSION 
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 In my study, I have evaluated the expression of xKazrinA, the subcellular 
localization and developmental roles of the xARVCF-catenin:xKazrinA complex. 
Distinct from reported protein interactions of ARVCF or KazrinA at the adherens 
junction or desmosome, I found that KazrinA associates with spectrin. Spectrin 
forms a cytoskeletal network that includes interactions with junctional constituents 
(schematic Fig. 60) (92, 97). While requiring further study, Kazrin appears to 
enhance p190B RhoGAP association with ARVCF-catenin. In any case, Kazrin’s 
modulation of RhoA, likely occurring in part via p190 RhoGAP, is relevant (based 
upon rescue analysis) to xKazrin-depletion effects in Xenopus embryos. In early 
amphibian development, I also observe that Kazrin depletion results in actin 
reorganization and reductions in cadherin levels and ectoderm integrity (modeled in 
Fig. 60). Finally, I find that xKazrin as well as xKazrinA play important roles in neural 
crest cell development and subsequent craniofacial development. My results form 
an initial outline of Kazrin’s role in the context of catenins, RhoA and p190B 
RhoGAP. 
 
Kazrin isoforms, expression and structure  
Xenopus Kazrin and its well-conserved vertebrate homologs are likely to represent 
a new protein group. Kazrin was originally identified as a cDNA (KIAA1026) 
expressed in human brain (72). In human keratinocytes, five Kazrin splice isoforms 
(A-E) were then reported, along with biochemical interactions and functional effects 
upon keratinocyte differentiation, small GTPases and actin or microtubule networks 
(73, 74, 77). Adding to Kazrin’s functional complexity is KazrinF, recently reported to  
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Figure 60. Working model of xARVCF:xKazrinA complex localization and function at the 
plasma membrane.  
 
Kazrin facilitates formation of the trimeric ARVCF:p190B RhoGAP complex, which localizes 
to the plasma membrane via association of Kazrin with spectrin. The p190B (and p190A) 
RhoGAP complex reduces RhoA activity locally in cortical/ junctional regions, thereby 
stabilizing the actin cytoskeletal structure supporting cell-cell contacts. An interaction of 
p120 with p190A RhoGAP at adheres junctions was previously reported (105).
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inhibit apoptosis through binding BAX (Bcl-2-associated X protein) and ARC 
(apoptosis repressor with caspase recruitment domain) in a human glioma cell line 
(75). We recently found that the original Kazrin cDNA isolated, KIAA1026, that we 
named it KazrinK, lacks the nuclear localization signal (NLS) sequence present in 
other isoforms. In Xenopus, our lab cloned the xKazrinA isoform from X. laevis, 
finding it highly homologous to human KazrinA, with 81% amino acid identity. 
Interestingly, the X. tropicalis KazrinA isoform is almost identical to that of X. laevis, 
except for 28 additional amino acids in the middle of coiled-coil region (Fig. 4). In 
my study, I found that X. laevis expresses both forms of xKazrinA (similar to human 
KazrinA), and named the longer form (similar to X. tropicalis KazrinA) as xKazrinB 
(Fig. 5). It is notable that the xKazrinB mRNA is maternally loaded (present in 
oocytes), and is thus more abundant in very early development, while xKazrinA 
shows a slightly later zygotic expression pattern (initiation coinciding with the mid-
blastula transition) (Fig. 6A). In adult tissues, xKazrinA is expressed ubiquitously 
whereas xKazrinB is present in more restricted contexts (Fig. 7A). Even as the 
functional differences of Kazrin isoforms are not yet known, these results suggest 
that xKazrinB may predominantly function during early development and in limited 
adult contexts, while xKazrinA operates slightly later in development and rather 
widely in the adult. So far, other isoforms of Kazrin have not been identified or 
cloned in Xenopus. However, my immuno-blotting using an antibody raised against 
the carboxy terminal 147 amino acids of xKazrinA, indicated the potential existence 
of KazrinC/D, and the SAM domain containing KazrinE, in Xenopus embryo and 
adult tissues (Fig. 6B and 7B). To further analyze the presence of such isoforms at 
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the mRNA and protein levels, RT-PCR primers and antibodies specific for each 
isoform need to be generated and applied. At present, we don’t understand why the 
xKazrinA and xKazrinB proteins are not resolved from one another in my immuno-
blots, or why xKazrinB appears to migrate on SDS-PAGE gels at the size of 
xKazrinA. To address these questions, we need to ectopically express both 
xKazrinA and xKazrinB and compare their migration. Also, it is possible that an 
unknown alternative splice variant of xKazrin reduces what we have assumed is 
xKazrinB to a size approaching that of xKazrinA.      
 Temporally, Xenopus Kazrin RNA and protein are expressed from the oocyte 
through adult-tissue stages, leaving open the possibility that Kazrin may 
continuously be needed for vertebrate life (Figs. 6 and 7). During embryonic 
development, Kazrin RNA is most prominently localized in the animal region of one-
cell stage embryos, in the anterior and dorsal parts of neurula embryos, and in the 
head region of tadpoles (Fig. 8). This expression pattern coincides with the 
developmental defects we observe upon xKazrin depletion in vivo, which includes 
abnormal neural fold and craniofacial development (Figs. 49, 50 and 54). As noted, 
an unsolved question is why xKazrinA and xKazrinB re not resolved from one 
another following immuno-blotting (Fig. 6B). 
 Structural prediction of the Kazrin protein using the “ScanProsite” proteomics 
server (http://expasy.org/tools/scanprosite/) indicated the presence of an amino-
terminal leucine zipper motif and central coiled-coil region (Fig. 3). Five helices were 
predicted in the coiled-coil sequence (Fig. 9). Functionally, the coiled-coil domain 
appears to be a binding module for other proteins such as envoplakin  
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and periplakin (73), with our previous work additionally indicating the binding of 
ARVCF-catenin. In the future, it will be interesting to determine which helix (or 
helices) out of the five predicted engages in each of Kazrin’s protein-protein 
interactions. Additionally, I demonstrated that the coiled-coil region is required for 
the homo-dimerization of xKazrinA (Fig. 11). At present, it is not clear whether 
Kazrin forms a dimer and/ or higher oligomers. By running non-denaturing native 
gels of bacterially-purified Kazrin protein, one may predict how many Kazrin 
molecule form a complex. Notably, Kazrin’s coiled-coil structure seems to be highly 
labile to protein degradation based on the results shown in Fig. 11, in which deletion 
of either Kazrin’s N- or C-terminal region decreased protein stability dramatically, 
while deletion of its coiled-coil region has no effect on stability. This result also 
suggests that both the N-terminal and C-terminal regions may work together to 
protect the coiled-coil domain. On the contrary, intact Kazrin protein is expected to 
be stable, because whereas Kazrin morpholino efficiently blocked Kazrin protein 
translation in vitro (Fig. 29A), a detectable decrease of endogenous Kazrin protein 
levels following Kazrin morpholino injection was not observed until neurula stages 
(Figs. 29B and 31). This indicates that the maternally loaded Kazrin protein is stable 
enough to survive until neurula stages. Thus, it will be interesting to study how 
Kazrin protein stability is regulated. One speculation is the post-translational 
modification of Kazrin. Conceivably, for example, phosphorylation may lead to the 
opening/ increased access of the coiled-coil domain, and Kazrin degradation.    
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Subcellular localization of the xARVCF:xKazrinA complex  
In common with the related p120- and delta-catenins, ARVCF is an 
established component of adherens junctions associating with cadherin membrane-
proximal regions (41, 81, 82). My tests indicate, however, that KazrinA is not 
associated with cadherin complexes (Figs. 14, 15 and 19).  
Kazrin is reported to directly bind periplakin and envoplakin, proteins present 
at peripheral desmosomal or inter-desmosomal regions (73). In cornified epithelia 
and other primary and cultured cell types, Kazrin was visualized at plasma-
membrane areas containing desmosomal and intermediate filament proteins, extra-
desmosomal areas enriched in cortical actin, and partially within cytoplasmic and 
nuclear compartments (73). In considering if ARVCF might localize to desmosomes 
in addition to adherens junctions, we considered the case of p0071-catenin, which 
likewise belongs to the p120 sub-family, and has been reported at both types of 
junctions (17, 19, 113). However, my experiments using mammalian cell or 
Xenopus embryo extracts, do not support ARVCF’s endogenous association with 
desmoglein 1 (Figs. 16 and 17). Furthermore, mouse desmoglein 3 and Xenopus 
ARVCF, over-expressed in Xenopus embryos, did not appear to interact (Fig. 18). 
This suggests that the ARVCF:KazrinA complex is not likely to be a core component 
of desmosomal junctions. 
 Yeast two-hybrid screening of xKazrinA resolved three (?2, ?1 and ?2) 
spectrin proteins as possible binding partners. Spectrins form a cytoskeletal network 
with actin filaments at the plasma membrane cortex, assisting in functions including 
plasma membrane and junctional strengthening, restriction of select proteins to 
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plasma membrane sub-domains, transduction of nerve action potentials, and 
contraction of heart cells (92, 114). In this study, I found that the xARVCF:xKazrinA 
complex associates with x?2-spectrin (Figs. 25 and 27), suggesting a novel 
interaction and localization of Kazrin and, by association, ARVCF-catenin. 
Previously, it was reported that the spectrin network associates with E-cadherin via 
ankyrin, contributing to lateral cell membrane integrity (97). I, however, found 
neither C-cadherin nor p120 co-precipitating with ?2-spectrin, despite significant 
homology within the cyto-domains of Xenopus E- and C-cadherin (80.5% identity) 
(Fig. 28). Possibly, cadherins such as C-cadherin form lesser interactions with the 
spectrin cytoskeleton in developmentally transitioning embryonic tissues. 
 It has been thought that the membrane localization of p120-catenin depends 
upon its association with cadherins in junctional areas. However, my study suggests 
that the ARVCF-catenin may additionally locate to the plasma membrane by binding 
to the spectrin cytoskeleton via Kazrin. Our yeast two hybrid screening, and 
preliminary in vitro binding data, showed that other p120-catenin subfamily proteins, 
namely delta-catenin and p0071, also bind to Kazrin. This implies that Kazrin 
mediated membrane localization may be a shared mechanism among p120-catenin 
subfamily members (Table1 and Fig. 61).  The decrease of ARVCF at the 
membrane, with increased ARVCF in the cytosol following Kazrin depletion 
supports this idea (Fig. 22), although I cannot exclude the possibility that decreased 
cadherin levels after Kazrin depletion contributed or was responsible for the 
cytoplasmic localization of ARVCF.   
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Figure 61. In vitro binding of Xenopus p120 sub-family catenins to xKazrinA.   
 
In vitro transcribed and translated Xenopus p120 sub-family catenins (HA-tagged) were 
tested for association with GST-xKazrinA following GST pull-down and immuno-blotting as 
indicated. Positive and negative controls respectively included xARVCF- and Xp120-
catenins.  In agreement with our yeast two-hybrid assays, xARVCF, xdelta (?)-catenin and 
Xp0071-catenin bound xKazrinA, whereas Xp120 did not. This suggests that Kazrin’s 
biochemical and presumably functional interactions involve some but not all p120 sub-
family catenins.
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 Another interesting question is the interplay that might occur between the two 
ARVCF distinct complexes suggested from my findings, namely the 
ARVCF:cadherin and ARVCF:Kazrin complexes. Surprisingly, two competition 
assays (Figs. 20 and 21) demonstrated that cadherins and Kazrin do not compete 
for binding to ARVCF, even though the two complexes are separable. This implies 
that a “free pool” of cytosolic ARVCF is able to move to either to cadherins at 
adherens junctions and/ or to the spectrin cytoskeleton where Kazrin is present, and 
that other unknown factors must allow the two ARVCF complexes to remain 
biochemically distinct, even if they reside in proximity at cell-cell contact regions.  
Under chemical cross-linking conditions, I observed increased 
cadherin:ARVCF binding as expected, but with reduced Kazrin:ARVCF association. 
Although further study is needed, I speculate this is due to ARVCF becoming 
covalently attached to more prevalent interacting proteins, or to those having higher 
affinity interactions (possibly including cadherin, PAPIN, ZO-1 and 2, FRMPD2, 
Vav2 and Erbin). Proteins binding weakly to ARVCF, such as Kazrin, might thus 
exhibit reduced interaction following cross-linking. Other possibilities are that the 
chemical modifications involved in cross-linking block ARVCF:Kazrin interactions 
from occurring, such that the loss of their association is more evident than any gains 
obtained from covalently linking existing complexes of the two proteins together.  
 
Cellular roles of the xARVCF:xKazrin complex 
 My study in Xenopus, and previous reports in human keratinocytes resolved 
Kazrin localization to cell:cell borders (73, 77). Earlier work predicted Kazrin’s 
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involvement in clathrin mediated endocytosis (76), which is known to contribute to 
cadherin internalization and thereby the modulation of junction function (55, 58, 60, 
115-118). Perhaps related are reports that p120 sub-family members, such as 
p120, ARVCF and delta-catenin, protect cadherins from endocytosis and lysosomal 
degradation, and may also chaperone cadherins to the plasma membrane (21-25, 
60, 71, 119-121). I speculate that Kazrin’s role in endocytosis, or the role of the 
ARVCF:Kazrin complex, may be linked to reduced levels of cadherin and adhesion 
following Kazrin depletion.  
If this were the case, one question would be how Kazrin or the 
ARVCF:Kazrin complex modulate cadherin endocytosis at the molecular level. 
Endocytosis requires cortical actin to be locally reorganized, with such changes 
involving the actions of small GTPases (69, 122). Multiple groups have reported 
Rho and Rac (and Cdc42) modulation by p120 sub-family catenins including 
ARVCF (22, 26, 61-63).  Kazrin is similarly implicated in RhoA modulation (77). My 
results point to negative xARVCF and xKazrin effects upon RhoA activity (Fig. 38), 
with the actin network becoming reorganized upon Kazrin depletion in vivo (Fig. 39). 
Requiring future study, I speculate that the ARVCF:Kazrin complex modulates 
RhoA activity at cell contacts, having an impact upon actin organization and thereby 
cadherin stability/endocytosis. Interestingly, Charrasse et al. found that 
constitutively active RhoA induces M-cadherin endocytosis and degradation 
(following p120-catenin dissociation from M-cadherin) (99). Although there is a 
discrepancy between my results and theirs regarding p120 (Kazrin knock-down in 
Xenopus embryos decreased catenin protein levels, whereas RhoA activation in 
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mouse myoblasts does not change endogenous p120 protein levels), both groups 
find that altered RhoA activity affects cadherin levels.  
 We identified p190B RhoGAP, ubiquitously expressed in mammals, as a 
novel binding partner of xKazrinA (Figs. 43 and 44). Since p190A RhoGAP interacts 
with p120-catenin (105, 106), and Xp190B with xARVCF (our results), p190 
RhoGAP members may be core RhoA effectors of the p120 subfamily proteins (or 
vice versa). This view may also relate to an earlier report implicating p190 RhoGAP 
in RhoA inhibition upon cadherin engagement (123). While I detected only weak 
endogenous association of Xp190B RhoGAP with xARVCF in vivo (Fig. 47), their 
interaction might be regulated, conceivably in response to Rac1, Rnd proteins or 
tyrosine phosphorylation of p190B by Src or Arg (Abl related gene) kinase (108, 
109, 124, 125).    
 
Developmental roles of the xARVCF:xKazrin complex 
 I resolved two distinct developmental phenotypes relating to the 
xARVCF:xKazrin complex following Kazrin depletion. General Kazrin knock-down 
by injecting the morpholino at the one-cell stage induced abnormal dorsal structures 
and ectoderm shedding at neurula stages, whereas dorso-anterior (e.g. future head/ 
brain region) depletion induced eye and craniofacial defects at tadpole stages. My 
results appear partially consistent with a previous report of Kazrin depletion in X. 
tropicalis. Sevilla et al. showed that Kazrin depletion (one-cell stage injections) in X. 
tropicalis embryos resulted in defects involving axis elongation, the eye and head, 
epidermal integrity and cardiac edema (78). Axis defects and cardiac edema were 
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not obvious in my study using X. laevis. Instead, I observed defects in dorsal 
epithelial closure after neural tube formation and the subsequent leakage of inner 
cells. Also, the loss of epidermal integrity following Kazrin morpholino injection at 
the one-cell stage was so severe in X. laevis that the embryos did not progress to 
tadpole stages when eye and head defects could be observed. At this time, I cannot 
readily explain the observed differences in Kazrin’s developmental phenotypes in 
these two closely related species. It should be pointed out that I used twice the dose 
of morpholino (20 ng) in my study, because lower doses (10 ng) did not induce a 
phenotype. Of note, axial elongation defects and cardiac edema are developmental 
defects generally originating in the mesoderm. Relative to the X. tropicalis study, it 
is possible that I did not deplete X. laevis Kazrin as effectively in the mesoderm due 
to differences in my injection methods (e.g. injection location or depth). To test this 
possibility, I could deplete Kazrin in a more directed fashion in mesodermal regions. 
Also, the more ectoderm-directed Kazrin depletion may help explain why there was 
not a greater than a 30-40% decrease in overall Kazrin protein level (Figs. 29 and 
31), the large rearrangement of ectodermal filamentous actin at blastular stages 
(Fig. 39), and graphic defects in dorsal neural fold and epidermal integrity (Figs. 49 
and 50), which originate from ectoderm.  
 During neural tube formation, ectoderm tissue on each longitudinal side of 
the dorsal midline first form a neural fold that moves towards the midline, makes 
contact and attaches. In my study, Kazrin depletion (morpholino injecting into one-
cell stage embryos), resulted in defects in dorsal midline sealing of the neural folds, 
leading to cell dissociation/ escape from the unsealed region (Figs. 49 and 50). This 
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phenotype appears is in keeping with my in situ hybridization showing that Kazrin 
mRNA is normally locally enriched within the neural fold region at these 
developmental stages (Fig. 8B). I found that ectopic expression of cadherin partially 
rescued such abnormalities following Kazrin depletion (Fig. 52). Taken together, this 
suggests that Kazrin plays a role in neural fold closure (dorsal epithelial closure 
after neural tube formation), perhaps via effects upon cadherin levels. 
 As mentioned earlier, Kazrin depletion in X. tropicalis gave rise to defects in 
eye and head development (78). Similarly, specific depletion of Kazrin (or ARVCF) 
in the future head region produced small head and eye phenotypes in X. laevis 
(about 90% after 20ng Kmo-S injection) (Figs. 54 and 56). Looking at later 
embryonic stages, my findings indicated that xKazrin and xARVCF are needed for 
craniofacial development, apparently as a consequence of their roles in neural crest 
cells (NCC). Neural crest is often described in three stages, neural crest cell 
establishment, migration and differentiation. Previous reports have demonstrated 
that RhoA participates in neural crest cell establishment (112), while my findings 
support Kazrin and ARVCF modulation of RhoA. Thus, the ARVCF:Kazrin complex 
may be involved in neural crest cell establishment.  It is also conceivable that the 
xARVCF:xKazrin complex regulates migration of neural crest cells. For example, 
Xenopus cadherin-11 is required for neural crest cell migration (126), and in human 
cancer cells (MDA231 and UMRC3), cadherin-11 mediated cell motility depends 
upon association of p120-catenin and p120-mediated RhoA inhibition (65). To 
clarify which stage(s) of neural crest formation require Kazrin, further studies are 
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needed, such as more extensive in situ analysis of neural crest markers (slug, snail, 
sox9 and etc.), as well as neural crest cell migration assays.  
 Technically, Kazrin or ARVCF morpholino was injected into the dorsal animal 
region of four cell stage embryos. However, in addition to later neural conributions, 
this region contributes to other tissues such as the epidermis, somites and 
notochord. To improve upon the specificity of targeting of Kazrin depletion to the 
future head region and to neural crest cells, the appropriate morpholinos need to be 
injected into head-fated blastomeres at the 16-cell or 32-cell stages. 
 Of note, our evaluation of neurula embryo sections (collaboration with Dr. 
Malgorzata Kloc, Methodist), demonstrated that the size of the neural tube is 
reduced after Kazrin depletion using Kmo-S (data not shown). This suggests 
another possible cause of eye and craniofacial defects. That is, a decrease in 
neural tissue upon Kazrin depletion may produce small eyes, a decreased number 
of neural crest cells and thereby subsequent cranial defects. It would be informative 
to score for defects in neural tube formation resulting from Kazrin depletion versus 
ARVCF depletion (Kmo-S or T, or ARVCF morpholinos), evaluating changes in 
neural tube size. Furthermore, Brdu (Bromodeoxyuridine) staining, or phospho 
Histone H3 staining of cross-sectioned neurula embryos, will assist in determining if 
there is a decrease in neural cell proliferation in response to Kazrin depletion, 
potentially contributing to reduced size of the neural tube.  
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Concluding remarks 
 My work indicates that Kazrin is a novel modulator of cadherin stability and 
Rho GTPase, likely occurring via its interaction with ARVCF-catenin and with p190B 
RhoGAP. My findings also suggest a new means by which ARVCF associates with 
junctional or cortical regions, and that is via Kazrin’s association with the spectrin 
cytoskeleton. In keeping with a prior study (78), I found that xKazrin is essential for 
ectoderm integrity and craniofacial development, with my rescue analysis extending 
Kazrin’s known functional interactions with xARVCF, cadherin and RhoA.  
 Xenopus Kazrin’s role in determining cadherin stability via RhoA modulation 
is in line with previous reports showing that Kazrin over-expression inhibits clathrin-
mediated endocytosis (76), and that Kazrin inhibits RhoA in human keratinocytes 
(77). Generally, however, there has been limited knowledge regarding Kazrin’s 
roles. Recently, Kazrin was found to be involved in keratinocyte differentiation and 
the cornified envelope formation of skin (73, 77). Here, my work suggests that 
Kazrin plays a role in cadherin-mediated cell-cell adhesion through interactions with 
p120-catenin subfamily members. With respect to such p120 subfamily proteins, 
classical cadherins have been considered as the sole plasma membrane “anchors”. 
However, my results raise an alternative possibility of membrane-localization via 
association with the spectrin cytoskeletal network. This will be discussed more in 
the following Future Directions. 
p120-catenin has been proposed to modulate RhoA in three manners:  1) 
p120 directly binds to RhoA and inhibits GDP dissociation as a RhoGDI (Rho GDP 
Dissociation Inhibitor) (61);  2) p120 activates Rac1 via Vav2 RhoGEF (Rho 
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Guanidine nucleotide Exchange Factor) and activated Rac1 indirectly inhibits RhoA 
activity (62);  and 3) p120 binds to p190A RhoGAP (Rho GTPase Activating 
Protein), and membrane-localized p190A inhibits RhoA locally (105). My results 
indicate that members of the Xenopus p120-catenin subfamily (excluding p120 
itself) inhibit RhoA via p190B RhoGAP, supporting the role of p190 RhoGAP family 
members in p120-catenin subfamily-mediated RhoA inhibition.    
A remaining question is if/ how Kazrin itself is regulated. Our study identified 
several novel binding partners of Kazrin including ARVCF-catenin, delta-catenin, 
p0071, spectrin and p190B RhoGAP. I propose that Kazrin is a scaffolding protein, 
enabling other proteins to interact. For example, ARVCF is complexed with spectrin 
via Kazrin, and thereby with the spectrin-actin cytoskeleton. However, it is unlikely 
that Kazrin binds to all of its binding proteins at the same time. Thus, a question is 
how the various possible interactions of Kazrin are regulated. It is conceivable that 
post-translational modifications may regulate Kazrin’s binding. It will be interesting 
to identify upstream signals that have an impact upon Kazrin and its interaction with 
other proteins. 
 Overall, my study has examined novel cellular and developmental roles of 
Kazrin, and broadens our understanding of p120-catenin subfamily proteins.   
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CHAPTER IV 
 
FUTURE DIRECTIONS 
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Interaction between p120-catenin subfamily members and Kazrin in 
mammalian cells 
 While my studies focused upon Xenopus (amphibian) Kazrin, it would be 
expected that mammalian Kazrin binds to mammalian p120-catenin subfamily 
proteins such as ARVCF and delta-catenin (but not p120 itself) given that Kazrin is 
highly conserved between human and Xenopus (81% amino acid identity). Our 
preliminary immuno-precipitation results show that Xenopus ARVCF binds to 
human KazrinK and E isoforms (data not shown), and based upon our yeast two-
hybrid screen, that Xenopus Kazrin may further bind to mouse delta-catenin and 
p0071. Interactions between the mammalian homologues of Kazrin and p120-
catenin subfamily members need to be tested by using co-immunoprecipitation 
(etc.) approaches from mammalian cell lines or tissues. Using mammalian systems 
may also provide benefits in overcoming difficulties I confronted using Xenopus. 
These will be discussed further below.  
 
Localization of endogenous Kazrin protein 
Our currently available antibodies directed against Kazrin did not reliably 
detect endogenous Xenopus Kazrin protein in immuno-fluorescence experiments. 
For example, my attempts using two rabbit polyclonal antibodies directed against 
human Kazrin, or three rabbit polyclonal antibodies directed against Xenopus 
Kazrin, failed to detect endogenous Kazrin in blastula ectodermal tissues. Thus, my 
co-localization studies were performed with exogenously expressed Kazrin. For this 
reason, it is possible that the signals I obtained did not accurately reflect the 
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localization of endogenous Kazrin. If the interaction between endogenous 
mammalian Kazrin and mammalian ARVCF is verified, co-localization of 
endogenous Kazrin and ARVCF (or other p120-catenin subfamily members) can be 
tested via immuno-fluorescence in mammalian cell lines and tissues. Also, using 
immuno-gold electron microscopy, the localization of Kazrin to p120-catenin 
subfamily members such as ARVCF (to adherens or desmosomal junctions), can be 
studied further.  
 
P120-catenin subfamily localization in relation to the spectrin cytoskeleton  
 It has generally been thought that p120 subfamily members localize to 
junctional areas via their association with cadherins. Interestingly, however, my 
study suggests that p120-catenin (and perhaps delta-catenin and p0071) indirectly 
interact with the spectrin cytoskeleton via Kazrin, thus becoming localized to plasma 
membrane areas independently of cadherins. To address this possibility, the effect 
of spectrin knock-down or knock-out on the membrane localization of p120-catenin 
subfamily members needs to be tested. It would be technically difficult to knock-
down spectrin using a morpholino approach in Xenopus, because information 
regarding the spectrin isoforms, genomic sequence and expression pattern is 
presently not fully available. Alternatively, spectrin knock-out mice, or derived 
knock-out (or knock-down) cell lines could be used in studies of spectrin’s role in 
p120-subfamily membrane localization. For this approach, ?2-spectrin would be a 
reasonable target for knock-out (or knock-down) because this spectrin is expressed 
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ubiquitously and also known to localize to the lateral membrane of epithelial cells 
similar to catenin proteins (97).  
 
Kazrin in human tissues 
 Work by others has shown that Kazrin participates in human keratinocyte 
differentiation and cornified envelope formation via RhoA modulation and binding to 
envoplakin and periplakin (73, 77). However, an RNA expression study showed that 
Kazrin RNA is expressed in most human tissues, implying Kazrin’s general and/or 
diverse functions in various tissues. Since envoplakin and periplakin are thought to 
be skin specific proteins, they are not likely to represent a general interaction of 
Kazrin. On the other hand, p120-catenin subfamily members are expressed 
ubiquitously in human tissues, with the exception of the more neural specific delta-
catenin (as an interesting aside, delta-catenin is much more widely expressed in 
Xenopus). Thus, it is plausible that Kazrin forms a more general complex with p120-
catenin subfamily proteins (excluding p120 itself). To address this possibility, the 
association of Kazrin with other p120-catenin subfamily members needs to be 
performed using extracts from varied mammalian cell lines or tissues.  
 I propose here that one molecular function of the ARVCF (and perhaps delta-
catenin and p0071):Kazrin complex is to inhibit RhoA activity. However, this must 
take into consideration findings that p120-catenin modulates Rho GTPase activity 
differently depending on cell context. For instance, p120 knock-down in MCF-7 cells 
increases Rac1 activity whereas it reduces it in MDA231 cells (64). Because I used 
extracts from whole Xenopus embryos for the RhoA activity assays, my results 
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reflect the net effects of Kazrin and the ARVCF:Kazrin complex on the modulation 
of RhoA activity. Thus, it is possible that this modulation occurs with opposing 
outcomes in differing tissues. To obtain a better over-view on the roles of p120-
catenin subfamily members, and of Kazrin, in small GTPase modulation, RhoA and 
Rac1 activity assays could be performed across cell lines derived from different 
tissues, or from extracts from different tissues, after depletion of Kazrin or p120-
catenin subfamily members. Perhaps also the use of in vivo reporters of RhoA and 
Rac1 activity would prove useful (127). 
 
Binding specificity of Kazrin 
A number of proteins have been shown to directly bind ARVCF-catenin. 
These include cadherins, RhoA, Vav2, ERBIN, FRMPD2, and ZO-1 and 2 (22, 41-
44, 62, 81, 82, 128, 129). The latter four bind the PDZ motif present in the carboxy-
terminus of ARVCF, delta-catenin and p0071.  Our study adds Kazrin as the newest 
binding partner of p120 subfamily members, excluding p120 itself. Kazrin seems to 
bind a relatively broad region of ARVCF (and likely other catenins), encompassing 
portions of the central Armadillo and carboxy-terminal domains. In turn, Kazrin’s 
extended coiled-coil domain associates with ARVCF, such that each protein’s 
coiled-coil regions presumably interact. Since the Armadillo domain of ARVCF 
exhibits some homology with p120-catenin (55% identity/ 74.4% similarity) (40), it 
may prove interesting to resolve the basis of specificity among different p120 
subfamily proteins.  
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Thus far, it seems that the coiled-coil domain is a protein-protein interaction 
module of Kazrin since it binds envoplakin, periplakin as well as ARVCF with this 
domain.  In addition, my study showed that Kazrin also dimerizes via the coiled-coil 
domain. Remaining questions include whether other novel binding proteins, 
spectrins and p190B RhoGAP, interact with the coiled-coil domain of Kazrin. 
Binding site mapping with Kazrin deletion mutants, and ultimately point mutants 
(possibly resolved via alanine scanning) will be useful to address this question.  
As shown in Figure 9, Kazrin is predicted to have six helices, five of which 
are located in the putative coiled-coil domain. We would very much like to solve the 
crystal structure of Kazrin (e.g. in collaboration with Dr. Richard Brennan), to better 
test our prediction. From this structural information, especially if Kazrin were co-
crystalized with ARVCF and other binding partners, we would obtain a deeper 
understanding of the binding specificity of Kazrin (and of ARVCF). 
 
Nuclear roles for the ARVCF-catenin:Kazrin complex 
We find that most Kazrin isoforms possess a defined functional NLS, and 
reside in both the nucleus and cytoplasm, as well as at cell-cell borders. However, 
Kazrin’s nuclear functions are uncertain. We previously determined that an NLS 
point mutant of Kazrin is excluded from the nucleus. One way to test the importance 
of the nuclear function of Kazrin will be compare the capacity of wild type Kazrin 
versus the NLS mutant in rescuing phenotypes arising from endogenous Kazrin 
depletion. For example, as shown in Fig. 56, wild type Kazrin can partilly rescue 
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Kazrin-depletion eye and craniofacial defects. Thus, one can test whether the NLS 
mutant Kazrin succeeds or fails to rescue this phenotype as well.    
Kazrin has been observed by others at the meiotic apparatus in unfertilized 
mouse eggs, with its localization changing following egg activation (79). In human 
keratinocytes, the liprin-like KazrinE isoform was found to associate with stable 
acetylated microtubules (74). Kazrin further binds plakin proteins in complex with 
intermediate filaments (73), and thus may conceivably associate with nuclear 
lamins. Nuclear lamin is a major component of a proteinous mesh/ network called 
the nuclear lamina. It is known that nuclear lamins and their associated proteins are 
involved in transcription through regulating the availability of transcription factors 
playing roles in signal transduction pathways (e.g. MAPK, Wnt/beta-catenin, TGF-
beta and Notch) (130). Interestingly, several transcription factors were found as 
putative interacting partners of xKazrinA from our yeast two-hybrid assay (results 
not shown). Thus, it can be postulated that Kazrin may associate with transcription 
factors near or at the nuclear lamina. Post-translational modification (e.g. 
phosphorylation) of such transcription factors by upstream signals may decrease 
transcription factor association with Kazrin, release them from the nuclear lamina to 
function in the nucleoplasm and more directly modulate gene expression.  
My and a prior study indicate that Kazrin affects the actin cytoskeleton via 
RhoA modulation (77), speculatively providing further means through which Kazrin 
might modulate gene activity. First, RhoA activates signal transduction pathways 
including JNK ( Jun N-terminal Kinase), p38 MAP kinase and the NF-kB pathway, 
up-regulating gene targets (131). Thus, by regulating RhoA, Kazrin may affect gene 
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programs. Second, the spatial organization of chromosomes is known to be 
important for correct gene expression. For example, transcriptionally inactive 
heterochromatin is localized to perinuclear and perinucleolar regions. When 
activated, gene regions are looped-out and positioned near trancriptionally active 
nuclear compartments such as cajal bodies (132). It is known that nuclear actin and 
myosin play roles in chromosomal movements (133, 134). Interestingly, a previous 
report suggested that Kazrin binds to coilin, a nuclear protein enriched in cajal 
bodies where snRNPs are involved in RNA splicing, and are modified and 
assembled (135). Thus, it is conceivable that Kazrin may affect transcriptional 
regulation via RhoA GTPase, or other protein partners. 
ARVCF further localizes to varied compartments including the nucleus (41, 
82, 136). Given that beta-catenin directly binds transcriptional modulators (e.g. 
TCF/LEF to activate genes within the canonical Wnt pathway), as does p120 (27, 
29, 31), it will be interesting to discern if Kazrin directly contributes to ARVCF (or 
delta- or p0071-catenin) effects upon gene activity. 
 
Roles of Kazrin in human tumor metastasis  
 E-cadherin is a well-known suppressor of tumor metastasis. Thus, malignant 
metastatic tumor cells show reduced levels of E-cadherin expression and ectopic 
expression of E-cadherin in malignant tumor cell lines inhibits metastasis. 
Consistent with its role in cadherin stability, p120-catenin levels are down-regulated 
in many malignant tumor tissues. Thus, to better understand the process of tumor 
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metastasis, it is significant to study the mechanism by which p120-catenin subfamily 
members stabilize cadherins.  
  I propose that Kazrin is a novel factor regulating cadherin stability in X. 
laevis and that Kazrin stabilizes cadherins through interactions with p120 sub-family 
members (excluding p120 itself) and small GTPases. It should be noted that p120 
sub-family members themselves are likely to have additional mechanisms of 
modulating cadherin levels, such as via their direct interactions with cadherin 
cytoplasmic tails, thereby reducing access of the endocytic machinery (exposure of 
endocytic signals) (137). In any case, to extend our knowledge of Kazrin in 
mammalian systems, cadherin protein level changes need to be monitored following 
Kazrin depletion in human cell lines. The effect of Kazrin on cell motility and 
invasion should also be tested, for example, using scratch-wound and cell-matrix 
invasion assays. In a more in vivo context, one could conduct tumor xenograft 
assays, using cell lines depleted for or over-expressing Kazrin. Alternative, more 
elegant transgenic or inducible knock-out approaches could be undertaken. Such 
experiments would assist in addressing the question of whether Kazrin plays a role 
as a metastasis suppressor, conceivably via the stabilization of cadherins. To 
determine the relevance of p120 sub-family members, cadherin and RhoA during 
this process, rescue experiments could be attempted via expression of p120 sub-
family members or cadherin and inhibition of RhoA activity in xenograft assays.  
 At present, no chromosomal mutation of the Kazrin locus (1p36.21) has been 
reported in human disease including tumors. However, it is known that tumor 
suppressor genes can be down-regulated at the epigenetic level such as by 
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promoter methylation. Thus, as a translational approach, changes in Kazrin RNA 
and protein levels during tumor progression should be studied by comparing Kazrin 
expression in normal tissue samples versus those from differing cancer stages 
(methods might include real time PCR, and in situ hybridization and immuno-
histochemistry of tumor tissue microarrays). To address if epigenetic changes might 
contribute to Kazrin expression in disease, promoter DNA methylation could be 
monitored by MSP (methylation specific PCR) and COBRA (combined bisulfite 
restriction analysis) (138, 139). Posttranslational modification of promoter histones 
in tumor tissues could also be monitored by chromatin-IPs using specific antibodies.  
 
Roles for the p120-catenin subfamily:Kazrin complex in eye development 
 Kazrin or ARVCF depletion in the head region induced eye and craniofacial 
developmental defects. Notably, in a previous study, p120 depletion in Xenopus 
showed a similar phenotype, and we recently found that delta-catenin depletion also 
evidenced the same defects, suggesting a general function for p120-catenin 
subfamily members in eye and craniofacial development. Since the craniofacial 
cartilage is a derivative of neural crest cells, defective neural crest cell 
establishment after Kazrin or ARVCF depletion explains craniofacial defects. 
However, the means by which the p120-catenin subfamily or Kazrin is involved in 
eye development remains to be determined.  
 The eye develops through a delicate, multi-step processes including primary 
eye field specification in the forebrain, neuroectoderm evagination from the 
forebrain, optic vesicle formation, lens placode induction, optic cup formation, lens 
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placode invagination, lens vesicle formation after separation from the epithelium, 
lens differentiation, retina development and neurogenesis, retinal pigment 
epithelium (RPE) development, vasculogenesis and iris development (140). Thus, it 
is difficult to predict process(es) in which the p120-catenin family and Kazrin play 
roles. 
 According to my research and that of others, the p120-catenin subfamily and 
Kazrin share molecular functions with respect to cadherin stability and RhoA 
modulation. Interestingly, double knock-outs of E- and N-cadherin in the mouse lens 
placode induced an absent-lens phenotype and microphthalmia (abnormally small 
eye) because the lens cells failed to separate from the surface epithelium and form 
the lens vesicle (141).  Furthermore, inhibition of RhoA activity in the lens resulted 
in abnormal lens development (cataract) and microphthalmia (142). These suggest 
that p120-catenin subfamily members and Kazrin may play crucial roles at least in 
lens formation. To test this, lens structures need to be carefully observed after 
Kazrin or p120-subfamily member depletion in Xenopus. To better test their 
potential downstream contributions to the observed eye defects, rescue 
experiments could be performed using ectopic expression of cadherins or Rho 
constructs.  
  In Xenopus and zebra fish, the non-canonical Wnt pathway is known to be 
important in early eye field specification. For example, depletion of either Xenopus 
Wnt4 or the Xenopus frizzled 3 (Xfz3) receptor reduced the expression of early eye 
markers such as Pax-6, Rx and Otx2, and induced eye defects (143, 144). Wnt4 
depletion-mediated eye defects were rescued by xFz3 and ?Dix-Disheveled (a non-
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canonical pathway activator).  Because beta-catenin could not rescue this defect, it 
suggests that the non-canonical Wnt pathway (beta-catenin independent) plays a 
role in the specification of the Xenopus eye field. In fish, Wnt11 and Fz5 are 
important in eye field formation (145). Coincidently, we previously reported that 
Xenopus p120-catenin activates the non-canonical Wnt pathway by de-repressing 
Kaiso-mediated repression of Xenopus Wnt11. Thus, there is a possibility that other 
p120 subfamily proteins such as ARVCF (and thus perhaps also Kazrin) may be 
involved in Wnt11 expression, and thereby in eye field formation. To test these 
possibilities, one could first examine changes in eye field specification after ARVCF 
or Kazrin depletion by performing whole-mount in situ hybridization for early eye 
markers such as Pax-6, Rx and Otx2. One could also monitor the changes in Wnt11 
mRNA levels after Kazrin or ARVCF depletion using RT-PCR and whole mount in 
situ hybridization.  
 Alternatively, it is possible that the Xenopus Wnt4/Frizzled3 (xWnt4/xFz3) 
mediated non-canonical Wnt pathway is a target of p120-catenin subfamily 
members:Kazrin complexes.  Depletion of xWnt4, xFz3, or two known Wnt4 gene 
targets (ELL-associated factor 2 or pescadillo) induced defects in craniofacial 
cartilage development and eye defects, which are similar to the phenotypic results 
following Kazrin or p120 sub-family members depletions. This may imply a 
functional interaction between xWnt4/xFz3 non-canonical pathway and p120-
catenin subfamily:Kazrin complex during Xenopus eye and craniofacial cartilage 
development. Furthermore, xWnt4 also plays a role in Xenopus kidney development 
(146), and our preliminary result showed that depletion of delta-catenin induced 
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abdominal edema and abnormal fluid accumulation due to kidney failure. Even 
though evidences are circumstantial yet, it will be interesting to test whether the 
p120-catenin subfamily:Kazrin complex affects the Wnt4 pathway. First, one can 
check the change of xWnt4 or xFz3 RNA level after Kazrin or ARVCF depletion. As 
mentioned above, p120-catenin protein up-regulates Wnt11 RNA via inhibition of 
Kaiso repressor. Similarly, nuclear p120-catenin subfamily:Kazrin complex may 
regulate transcription of xWnt4 or xFz3 by an uncharacterized mechanism. The 
activity change of non-canonical Wnt4 pathway can be further monitored with a Jun 
reporter assay, which has been used as a (less than ideal) read-out of non-
canonical Wnt pathway activity. Second, one can test physical association of the 
ARVCF:Kazrin complex with ELL-associated factor 2 (EAF2) or pescadillo using co-
immunoprecipitation assays.  EAF2 and pescadillo are gene targets of non-
canonical Wnt4 pathway and depletion of either protein induces eye defects, loss of 
expression of eye markers and craniofacial defects (144, 147). At the molecular 
level, EAF2 is a component of the RNA Pol II elongation complex and pescadillo is 
a multi-functional nuclear protein involved in ribosome biogenesis, cell proliferation, 
RNA transcription, DNA replication and chromosome stability. Thus, it is expected 
that these proteins play a role in expression of genes required for eye and neural 
crest cell development. If interaction between p120-catenin subfamily:Kazrin 
complex and EAF2 (or pescadillo) is authenticated by binding assays, further 
experiments identifying gene targets will be performed. For example, microarray 
results from depletions of Kazrin, p120-catenin subfamily, EAF2 or pescadillo in 
Xenopus embryos will be compared and genes co-regulated by these depleted 
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proteins will be categorized as potential gene targets of interaction between p120-
catenin:Kazrin and EAF2 (or pescadillo).  
 
 
 
Summary 
 During my thesis work, I characterized the roles of Xenopus Kazrin at both 
cellular and developmental levels, examining for example, properties such as 
cadherin stabilization via RhoA modulation, ARVCF-membrane localization, 
ectoderm integrity and neural crest cell development. With respect to future 
directions, I am proposing to extend our knowledge obtained from use of Xenopus 
to study of mammalian systems and human cancer. In addition, the uncharacterized 
roles of Kazrin and p120-catenin sub-family members during eye development 
needs to be addressed.   
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CHAPTER V 
 
MATERIALS AND METHODS
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DNA Constructs 
 pCS2/myc-xKazrinA, pCS2/myc-xKazrinA ?N, pCS2/myc-xKazrinA ?M, 
pCS2/MT-xKazrinA ?C, pCS2/HA-xARVCF-1ABC, pMAL/xARVCF-1ABC were 
generated by Travis Vaught. pCS2/xKazrinA was made by PCR amplification of 
xKazrinA cDNA from pCS2/MT-xKazrinA and cloning into pCS2 vector. 
pGEX/xKazrinA was produced by cloning PCR-amplified xKazrinA cDNA into 
pGEX4T-1 (GE healthcare). Xenopus ?2-spectrin and p190B cDNAs (IMAGE 
#5571051 and # 6635626, respectively) were purchased from Open Biosystems 
(Thermo Fisher Scientific Inc.), and placed into pCS2/HA. Human p190B RhoGAP 
cDNA was a gift of Jeffrey M. Rosen (148), and subcloned into pCS2/HA. 
pCS2/myc-GFP-Dsg1-tail was obtained as a gift of Michael W. Klymkowsky (U. 
Colorado). pCS2/flag-mDsg3 was cloned by Hong Ji. pCS2/HA-Xdelta-catenin 
construct was cloned previously (25). pCS2/HA-Xp0071 was a gift of Kris Vleminckx 
(unpublished; U. Ghent).  
 
Antibodies and Reagents 
 Anti-Myc (9E10) and anti Xenopus E-cadherin antibody (5D3), respectively 
developed by J. Michael Bishop and Barry M. Gumbiner, were obtained from the 
Developmental Studies Hybridoma Bank (NICHD and U. Iowa). xC-cadherin, 
xARVCF, Xp120 and x?-catenin antibodies are previously described(22). To make 
Xenopus Kazrin specific antibody, carboxy-terminal 147 amino acids were cloned in 
pGEX 4T-1 vector and bacterially purified protein was injected into a rabbit for 
inoculation (UT MDACC Core Facility, Bastrop TX).  IgG was purified from a rabbit 
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bleed using protein A sepharose and specificity of purified antibody was tested 
against ectopically expressed Xenopus Kazrin in embryo lysates.  Other antibodies 
were purchased from commercial sources (HA, Sigma H9658 and Santa Cruz 
SC805; ?-actin, Sigma A2066; GAPDH, Santa Cruz SC-25778; Rho (-A,-B,-C), 
Millipore 05-822, ; Desmoglein 1, BD Transduction Laboratories 610273; 
plakoglobin, BD Transduction Laboratories 610253; human ARVCF, Abnova 
H00000421-M01).  
 Dynasore and alcian blue dye were purchased from Sigma (D7693 and 
A3157, respectively). DTSSP was purchased from Thermo scientific (21578).  
 
Yeast Two-Hybrid 
 Screening using full-length xKazrinA employed an adult mouse brain cDNA 
library in collaboration with Hybrigenics’ ULTImate Y2H™ (149). 281 positive clones 
were obtained, then sequenced and analyzed.   
 
xKazrin RT-PCR Primers and Morpholinos. 
 Primers used for RT-PCR analysis of xKazrin were: F1: 5’-
AGCTTCGGCGCCAAGCCAAGG-3’, R1 : 5’-ACTCTGACAGCTTGCCGGTC-3’, K1: 
5’-CGGACCTAGTAAGCCAAATGG-3’, K2: 5’-CTGTGGATGTCCGTGGTACAG-3’, 
K3: 5’-CCAGGCATTGCTAGAGAGTGG-3’ and K4: 5’-
TCCGTTGCTTCCTTGGCTTGG-3’.  
 We employed a previously characterized translation blocking morpholino 
directed against xKazrin (Kmo-T) (xKazrin cDNA –4 to +21: 5’-
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GCTTGTTATCTTCCATCATCTTCAG-3’) (78), and newly designed splicing 
blocking morpholino against xKazrin pre-mRNA (Kmo-S) (5’-
AAACCATTTTTGCCCTCACCTTTCT-3’). A standard control morpholino (Cmo) 
from Gene Tools LLC was used as a negative control (5’-
CCTCTTACCTCAGTTACAATTTATA-3’). 
 
Pull-down Assays 
 For in vitro MBP pull-downs involving Xp190B, xARVCF and xKazrinA, 4mg 
of pCS2/HA-Xp190B DNA was in vitro transcribed and translated using the TNT 
SP6 High-Yield Wheat Germ Protein Expression System (Promega), following the 
manufacturer’s protocol. Synthesized Xp190B protein was then incubated with 1mg 
of bacterially purified GST-xKazrinA and/or MBP-xARVCF in pull-down buffer (PBS, 
1mM EDTA, 0.1% NP-40, 100ng/ml BSA) and pulled-down using amylose-resin.  
 A GST pull-down assay between GST-xKazrinA and Xp190B was performed 
following the same procedure. For pulling down GST-xKazrinA, Glutathione 
Sepharose 4B (GE healthcare) was used. 
 
Xenopus Embryo Manipulations and Co-Immunoprecipitations 
 Induction of female Xenopus laevis, in vitro fertilization of eggs, and e-mbryo 
injections were carried out using standard methods (150). Capped mRNAs for 
injection were generated using mMessage mMachine kits (Ambion). Embryos were 
incubated at 18oC to stage10 (early gastrula), lysed in embryo IP buffer (50mM Tris-
HCl pH 7.4, 1% Triton X-100, 150mM NaCl, 1mM EDTA, 1 mM PMSF, 1mM 
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Na3VO4, 1mM NaF, and 1mg/ml each of Aprotinin, leupeptin and pepstatin), 
centrifuged, and the supernatants divided for immunoprecipitation. Immune 
complexes were precipitated using Protein-A/G agarose beads (Santa Cruz), and 
subjected to Western blotting.  
 
Cell-cell dissociation assay and re-association assay 
 For assay of cell-cell dissociation, naive ectoderm tissue fragments (animal 
caps) were isolated from late blastula embryos (stages 9-10), placed in 0.6X MMR 
solution with or without 2mM EGTA and rotated at room temperature for 2-3 hours 
until control morpholino injected animal caps were completely dissociated. 
 For cell re-association assay, after isolation of animal caps outer layer was 
separated from inner cells and discarded. Remained inner cells were completely 
dissociated in Ca/Mg free MBS solution by pipetting, and then rotated at room 
temperature in the presence of 2mM CaCl2.  
   
Immunofluorescence 
For Xenopus ectoderm confocal microscopy, in vitro transcribed Myc-
xKazrinA RNA and/or HA-xARVCF RNA were injected into the animal pole of one-
cell stage embryos. Vitelline membranes of late blastula embryos (stage 9) were 
manually removed, followed by 2 hour fixation in MEMFA and methanol 
dehydration. Embryos were then serially re-hydrated with PBS-diluted methanol, 
incubated 1 hour in blocking buffer (20% goat serum in PBST), incubated 3 hours 
with primary antibody, washed 1 hour with PBST, incubated 3 hours with secondary 
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antibodies and washed (3-4 times) with PBST. Blastula ectoderm tissue (animal 
caps) were isolated, and mounted on glass slides. Images obtained from an 
Olympus IX-70 microscope were captured using Olympus Fluoview FV500 
software, and adjusted for brightness in select cases using Adobe Photoshop 
software. 
For actin staining, naive ectoderm (animal caps) isolated at stage 10 was 
fixed with 3.7% Paraformaldehyde and 0.25% glutaraldehyde in PBST for 30 
minutes at room temperature. After rinsing with PBST, samples were incubated 
overnight at 4°C with Alexa Fluor 488 – phalloidin (Molecular Probes/ Invitrogen). 
Stained ectodermal tissues were washed with PBST, mounted and viewed under a 
confocal microscope.  
 
In Vitro Rho Activity Assay 
 In vitro Rho activity assays were performed as described, previously (25). 
Briefly, Xenopus embryos injected with xARVCF and/or xKazrinA morpholinos were 
subject to lysis buffer (25mM HEPES pH7.5, 150mM NaCl, 10mg MgCl2, 1% NP-40, 
1mM EDTA and 2% glycerol), and lysates incubated with recombinant GST-
Rhotekin RBD (Rho Binding Domain) immobilized to glutathione-SepharoseTM 4B 
(GE Healthcare Life Science), followed by pull-down and subsequent SDS-
PAGE/Western blotting detection of active Rho. 
 
Crosslinking co-IP 
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 For crosslinking co-IP, embryos were lysed in crosslinking buffer (50mM 
HEPES pH7.5, 150mM NaCl, 1% Triton X-100, 2mM EDTA and protease inhibitors) 
and extract was crosslinked with DTSSP dissolved in 5mM sodium citrate buffer for 
30 minutes at room temperature. Reaction was stopped by adding Tris pH7.5 
(50mM final concentration) and proteins were precipitated with specific antibodies. 
Precipitants were de-crosslinked by adding ?-mercaptoethanol and DTT, and 
subjected to SDS-PAGE/western blotting. 
 
Membrane fractionation 
 Membrane fractionation was performed as described previously (151). 
Embryo extract was prepared with homogenizing buffer (250mM sucrose, 10mM 
HEPES, 2mM MgCl, 1mM EGTA and 0.5mM EDTA) and then centrifuged at 750g 
for 5 minutes. For isolating cytoplasmic soluble fraction, supernatant was 
transferred to new tube and re-centrifuged at 21,000g for 5 minutes. Supernatant 
was taken as cytosolic fraction extract. For isolating membrane fraction, pellet from 
initial centrifugation was dissolved in Y buffer (0.5% NP40, 150mM NaCl, 10mM 
HEPES and 1.5mM EDTA), re-centrifuged at maximum speed for 10mins, and 
supernatant was kept as membrane fraction.  
 
Alcian blue staining 
 For cartilage staining, embryos were fixed in 95% ethanolovernight and 
incubated in alcian blue solution (150mg alcian blue in the mixture of 800ml 95% 
ethanol and 200ml acetic acid) overnight. Stained embryos were washed with 95% 
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ethanol for 4-5 hours. Embryos were soaked in 2% KOH for 1-2 hour(s) until skin 
became soft. After removal of the skin, cartilage pictures were taken. 
 
Whole mount In situ hybridization 
 Whole mount in situ hybridization was performed following the protocol 
reported previously (150). In brief, embryos were fixed in MEMFA fixative, 
dehydrated in methanol, re-hydrated with serially diluted methanol, re-fixed with 4% 
paraformaldehyde, pre-hybridized in hybridization buffer (50% formamide, 5X SSC, 
1mg/ml yeast RNA, 100ug/ml heparin, 1X Denhart’s solution, 0.1% Tween 20, 0.1% 
CHAPS and 10mM EDTA) at 60°C for 6 hours and hybridized with digoxigenin 
labeled RNA probes at 60°C overnight. After washed with SSC solution, embryos 
were incubated in blocking solution (2% blocking reagent in maleic acid buffer) at 
room temperature for 1 hour and then incubated with anti-digoxigenin antibody 
conjugated to alkaline phosphatase overnight at 4°C. Then, target RNAs were 
visualized by color reaction with NBT/BCIP substrate for alkaline phosphatase and 
embryos were re-fixed in Bouin’s fixative overnight. After washing with 70% ethanol 
several times until yellow color from Bouin’s fixative disappeared, embryos were 
bleached in bleaching solution (0.5X SSC, 5% formamide and 1.2% peroxide) and 
observed under stereomicroscope. 
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